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Biomaterials have shown promise for treatment of injuries to the nervous system. 
Laminin, a glycoprotein, forms distinct polymers under neutral (pH 7; neutral laminin, nLam) or 
acidic (pH 4; acidic laminin, aLam) conditions (1, 2). aLam promotes significant axonal growth 
(2), making it of interest as a therapeutic for nervous tissue injuries.  
In this thesis, instead of as a substrate, we evaluate unbound aLam. In Chapter 2.1, we 
use an in vitro model system to investigate the mechanisms underlying aLam growth promotion. 
Results indicate: 1) laminin can act as a signaling molecule promoting outgrowth of adult 
neurons in vitro; 2) aLam is a more efficient promoter of outgrowth than nLam; 3) both polymers 
signal through α1 and α3 integrins without increasing their expression; 4) aLam, increases α3 
integrins when α1 integrins are blocked; 6) aLam increases vinculin, a focal adhesion complex 
protein.  These findings indicate that aLam promotes outgrowth by increasing integrin activation 
to enhance neurite outgrowth.   
In Chapter 2.2 microcontact printing and live imaging were combined to evaluate aLam’s 
effects on growth dynamics.  Our results suggest: 1) neurons will adhere to stamps and grow in a 
directional manner in culture; 2) cells did not adhere or grow well during live imaging.  Results 
indicate potential for directing neuronal outgrowth, but optimization is necessary to assess 
growth dynamics.  
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Peripheral nerve injury (PNI) and spinal cord injury (SCI) are devastating. In Chapter 3.1 
we investigate aLam’s treatment potential in PNI.  R esults indicate that aLam treatment: 1) 
increased presence of larger diameter axons; 2) facilitated compliance in treadmill walking; 3) 
alleviated autophagia; 4) did not affect motor function, axon number or myelination.  These data 
show that aLam treatment elicits an axon growth response without affecting motor function 
recovery.  Further research is needed to optimize treatment for functional improvements.    
Chapter 3.2 evaluates aLam treatment after SCI.  Results show that aLam treatment:  1) 
did not affect axon regeneration; 2) decreased astrocyte activation; 3) did not affect neuropathic 
pain or motor outcomes.  The data indicate treatment did not lead to functional improvements.  
Further research is needed to investigate the potential of aLam for SCI repair. 
v 
TABLE OF CONTENTS 
PREFACE ................................................................................................................................. XIV 
1.0 INTRODUCTION ........................................................................................................ 1 
1.1 BIOMATERIALS ................................................................................................ 2 
1.1.1 Laminin .......................................................................................................... 4 
1.1.2 Acidic Laminin Polymer............................................................................... 4 
1.2 INTEGRIN RECEPTORS AND THE FOCAL ADHESION COMPLEX .... 5 
1.3 MICROCONTACT PRINTING FOR LIVE IMAGING ASSESSMENT..... 8 
1.4 PERIPHERAL INJURY AND REPAIR ......................................................... 10 
1.5 SPINAL CORD INJURY AND REPAIR ........................................................ 12 
1.6 GOALS OF THESIS ......................................................................................... 13 
2.0 SIGNALING MECHANISMS OF ACIDIC LAMININ-MEDIATED AXON 
GROWTH IN VITRO ................................................................................................................ 15 
2.1 ACIDIC LAMININ POLYMER AND INTEGRIN-MEDIATED 
SIGNALING ....................................................................................................................... 17 
2.1.1 Introduction ................................................................................................. 17 
2.1.2 Materials and Methods ............................................................................... 18 
2.1.2.1 Reagents ............................................................................................... 18 
2.1.2.2 Neuron cultures ................................................................................... 18 
vi 
2.1.2.3 Immunostaining and Axon Length Quantification .......................... 20 
2.1.2.4 Integrin Blocking................................................................................. 21 
2.1.2.5 Electrophoresis and Western Blot ..................................................... 21 
2.1.2.6 Protein Staining and Visualization .................................................... 22 
2.1.2.7 Statistical Analysis .............................................................................. 23 
2.1.3 Results .......................................................................................................... 23 
2.1.3.1 aLam promotes neurite growth from adult DRG neurons in vitro 
better than nLam ............................................................................................... 23 
2.1.3.2 aLam and nLam exhibit differential interactions with α1 and α3 
integrins .............................................................................................................. 24 
2.1.3.3 Blocking α1 integrin leads to laminin structure-dependent changes 
in the relative expression of α3 integrin ........................................................... 27 
2.1.3.4 The presence of aLam increased relative amounts of Vinculin ...... 28 
2.1.4 Discussion..................................................................................................... 29 
2.2 MICROCONTACT PRINTING OF POLY-D-LYSINE FOR LIVE 
IMAGING ANALYSIS OF AXON GROWTH ............................................................... 33 
2.2.1 Introduction ................................................................................................. 33 
2.2.2 Materials and Methods ............................................................................... 34 
2.2.2.1 Reagents ............................................................................................... 34 
2.2.2.2 Preparing culture dishes ..................................................................... 34 
2.2.2.3 Alternate coverslip preparation ......................................................... 35 
2.2.2.4 Microcontact Printing of Poly-D-lysine ............................................ 35 
2.2.2.5 Cell Culture and Live Imaging .......................................................... 36 
vii 
2.2.2.6 Statistical Analysis .............................................................................. 37 
2.2.3 Results .......................................................................................................... 37 
2.2.3.1 Microcontact Printing with SDS release layer is an efficient way of 
creating patterned PDL for axonal guidance in culture ................................ 37 
2.2.3.2 Neurons did not adhere strongly enough for live imaging outgrowth 
assessment ........................................................................................................... 38 
2.2.4 Discussion and future studies ..................................................................... 40 
3.0 TESTING OF ACIDIC LAMININ FOR NERVOUS TISSUE REPAIR ............. 42 
3.1 ACIDIC LAMININ FOR PERIPHERAL NERVE REPAIR ....................... 43 
3.1.1 Introduction ................................................................................................. 43 
3.1.2 Materials and Methods ............................................................................... 45 
3.1.2.1 Surgical Procedures ............................................................................ 45 
3.1.2.2 Post-Surgery Procedures .................................................................... 47 
3.1.2.3 Motor Function Assessment ............................................................... 48 
3.1.2.4 Immunohystochemistry ...................................................................... 49 
3.1.2.5 Semi-thin nerve sections ..................................................................... 50 
3.1.2.6 Myelin Quantification ......................................................................... 51 
3.1.2.7 Statistical Analysis .............................................................................. 51 
3.1.3 Results .......................................................................................................... 51 
3.1.3.1 Laminin treatment resulted in decreased autophagia ..................... 51 
3.1.3.2 aLam treatment increased compliance for treadmill walking ........ 52 
3.1.3.3 No difference in peroneal function index at 70 dpi .......................... 53 
viii 
3.1.3.4 aLam treatment increased the number of large diameter axons at 
70dpi….…………………………………………………………………………54 
3.1.3.5 No difference in myelination of nerve between groups ................... 54 
3.1.4 Discussion..................................................................................................... 55 
3.2 ACIDIC LAMININ FOR SPINAL CORD REPAIR ..................................... 57 
3.2.1 Introduction ................................................................................................. 57 
3.2.2 Materials and Methods ............................................................................... 59 
3.2.2.1 Surgical Procedures ............................................................................ 59 
3.2.2.2 Post-Surgery Procedures .................................................................... 61 
3.2.2.3 Motor Function Assessment ............................................................... 62 
3.2.2.4 Sensory Function Assessment ............................................................ 63 
3.2.2.5 Anterograde and Retrograde Tracing .............................................. 64 
3.2.2.6 Histology .............................................................................................. 65 
3.2.2.7 Immunohistochemistry ....................................................................... 65 
3.2.2.8 Spared Tissue Quantification ............................................................. 66 
3.2.2.9 Statistical Analysis .............................................................................. 66 
3.2.3 Results .......................................................................................................... 66 
3.2.3.1 Laminin did not affect motor function recovery .............................. 66 
3.2.3.2 Laminin did not affect sensory function recovery ........................... 68 
3.2.3.3 Laminin polymers decrease astrocyte activation ............................. 68 
3.2.3.4 aLam did not affect axon intensity at injury site ............................. 69 
3.2.3.5 Anterograde and Retrograde tracing ................................................ 70 
3.2.3.6 Polymerized laminin had no effect on tissue sparing....................... 71 
ix 
3.2.4 Discussion..................................................................................................... 72 
4.0 SUMMARY AND GENERAL DISCUSSION ........................................................ 73 
BIBLIOGRAPHY ....................................................................................................................... 77 
x 
 LIST OF TABLES 
Table 1 Working Concentrations of Primary and Secondary Antibodies .................................... 22 
xi 
LIST OF FIGURES 
Figure 1. Schematic of Focal Adhesion Complex ......................................................................... 6 
Figure 2 Microcontact Printing with 10% w/v SDS release layer ................................................. 9 
Figure 3 In vitro model system .................................................................................................... 16 
Figure 4 Schematic of rat spinal cord with dorsal root ganglia (DRGs)...................................... 20 
Figure 5 Neuronal Outgrowth Profiles.  ...................................................................................... 24 
Figure 6 Neuronal Outgrowth Profiles after Antibody Blocking. ............................................... 26 
Figure 7 Increased α3 Integrins Expression After α1 Block. ....................................................... 28 
Figure 8 Vinculin Protein Expression Levels. ............................................................................. 29 
Figure 9 Schematic of modified culture dish ............................................................................... 37 
Figure 10 Image of poly-D-lysine stamp on PDMS coated coverslip. ........................................ 38 
Figure 11 Live Imaging aLam. .................................................................................................... 39 
Figure 12 Integrin Expression of DRG cells in culture and tissue............................................... 44 
Figure 13 Peroneal Nerve Injury. ................................................................................................. 47 
Figure 14 DigiGait® Automated Treadmill walking device and software. .................................. 49 
Figure 15 Compliance for Automated Treadmill Walking.......................................................... 52 
Figure 16 Peroneal Function Index.   ........................................................................................... 53 
Figure 17 Peroneal Nerve Regeneration.. .................................................................................... 54 
Figure 18 Myelin Quantification. ................................................................................................. 55 
xii 
Figure 19 Integrin Expression after SCI.   ................................................................................... 59 
Figure 20 Spinal cord injury and injection................................................................................... 61 
Figure 21 BBB and Horizontal Ladder. ....................................................................................... 63 
Figure 22 BBB and Horizontal ladder. ........................................................................................ 67 
Figure 23 Gait Analysis.   ............................................................................................................ 67 
Figure 24 Thermal Hyperalegesia. ............................................................................................... 68 
Figure 25 Astrocyte Activation and Axons.................................................................................. 69 
Figure 26 Tracing Quantification.   .............................................................................................. 70 
Figure 27 Tissue Sparing. ............................................................................................................ 71 
xiii 
PREFACE 
Many people have provided essential support in order for this thesis to be realized. 
Primarily, I have to thank my daughter, Kaila, my inspiration, whose enthusiasm about my 
research and unfailing belief in me and my love of science, has rekindled in me a passion and 
energy that at times was in danger of burning low.  
Many thanks and limitless gratitude to my mentor, Martin Oudega, who gave me the 
opportunity to work in his lab and has been patient in teaching both laboratory and life skills and 
for creating an amazing environment in which to work and learn; to my committee, Tracy Cui, 
Yadong Wang and Adam Feinberg who have donated their time, expertise, and at times their lab 
equipment and personnel to bring this to fruition; to Katarina Vajn, Gaby Ritfeld, Tabitha 
Novosat and the past and current members of the Spinal Cord Repair Lab; to all of the staff and 
faculty of the Center for Biological Imaging, especially Doris Clay and Callen Wallace, the CBI 
is full of remarkable personnel who have provided many answers to my many questions and 
allowed me to use their remarkable equipment; to the PICAN lab and collaborators who started 
me on t his great journey; and lastly to my family, both born and chosen, you’ve always 
supported, encouraged and challenged me and there is no question that I succeed where others 
have failed not due to my own unique abilities or drive, but because of my extraordinary support 
group. 
xiv 
1.0  INTRODUCTION 
Spinal cord injury (SCI) and peripheral nerve injury (PNI) lead to loss of motor and sensory 
function.  Motor vehicle accidents have historically been a main cause of these types of nervous 
tissue trauma.  In recent years in the United States, neuropathies due to diabetes has increasingly 
contributed to the overall number of people with PNI-related functional impairments (3).  The 
spinal cord contains long descending motor axons originating from neurons in various brain 
nuclei.  T he peripheral nerves contain long motor and/or sensory axons from neurons in the 
ventral spinal cord and dorsal root ganglia, respectively.  Trauma to these anatomical structures 
typically severs these axonal tracts thereby disrupting the information to and from the target 
cells.  Neuronal death due to an injury to the spinal cord and peripheral nerve is relatively limited 
because of the typically long distances between cell body and the injury site.  Thus, promoting 
recovery of function after PNI and SCI by eliciting re-growth (regeneration) of the severed axons 
is a f easible repair strategy.  On e approach to axonal regeneration is to introduce exogenous 
axonal growth-promoting molecules to the site of injury.  In this thesis, we have investigated the 
molecular mechanisms of action and the nervous tissue repair potential of polymers of acidic 
laminin (aLam), an injectable axonal growth-promoting biomaterial.   
1 
1.1 BIOMATERIALS 
There is not yet a consensus among scientists and engineers on what constitutes a biomaterial, 
but here it is loosely defined as: “a naturally occurring or synthesized material exposed to a 
biological specimen separate from its origin to elicit a response.” The emergence of biomaterials 
for regeneration and increased collaborations between engineers, basic and translational 
scientists, and clinicians hold promise for the development of effective therapies for spinal cord 
and peripheral nerve  injury.  A plethora of biomaterials are available and have been tested in 
various models of SCI (4) and PNI (5). Biomaterials may provide structural support and/or serve 
as a delivery vehicle for factors to arrest growth inhibition and promote axonal growth. 
Designing materials in order to address the specific repair needs of the damaged central nervous 
system is crucial and possible with current technology.   
In general, biomaterials for nervous tissue repair are employed for their ability to provide 
passive structural or active growth support to damaged axons; some offer both through 
functionalization with biologically active peptide sequences.  N umerous natural and artificial 
materials have been tested for their efficacy in repairing the injured central (6, 7) and peripheral 
nervous system (8, 9).  Application of some of these resulted in functional improvements 
demonstrating their repair potential.  As introduced above, axonal regeneration is considered an 
important repair mechanism for the injured nervous system and promoting regeneration of 
severed axons after injury could elicit anatomical and behavioral recovery.  
Most biomaterials designed and produced in the laboratory and tested for their efficacy to 
repair the injured peripheral nerve and spinal cord are polymers.  P olymers have numerous 
biomedical applications due to their vastly diverse properties.  Typically, polymers are large 2- 
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or 3-dimensional molecules composed of repeating units (10, 11).  Polymers can be obtained 
from natural sources including plants, animals, and deoxyribonucleic acid, or be fabricated 
synthetically in a laboratory.  Natural polymers are widely available and tend to undergo highly 
controlled synthesis resulting in regular structures; however, they often contain contaminating 
molecules and are difficult to sterilize (11).  S ynthetic polymers are easier to sterilize, but are 
typically susceptible to the chosen process of synthesis often causing irregularities in structure 
and composition (11).   
Currently, there is a lack in agreement in the literature on the optimal characteristics of 
biomaterials for promoting neural regeneration and repair.  However, there is increasing 
theoretical and experimental evidence for the use of polymers for repair of soft tissue such as 
nervous tissue (6, 7).  An important advantage of some polymers for nervous tissue repair is that 
they can be designed for in situ polymerization and/or cross-linking, therefore requiring less 
invasive approaches to be applied, i.e. injection. Other advantages are that they can be fabricated 
to degrade within a s pecific time window, they are non-cytotoxic, and they have similar 
mechanical properties as that of the host tissue to minimize fibrolysis (12).   
A variety of natural biomaterials mostly present within the extracellular matrix (ECM) 
provide structural and growth support to axons in the developing (13, 14), mature (15), and 
damaged (16) nervous tissue.  Laminin, collagen, fibronectin, vitronectin, and 
proteoglycans(PG)/glycosaminoglycans (GAGs) (14) are all members of this particular group of 
materials.  Many axonal growth-promoting ECM components signal through integrin receptors 
(17) that often bind the Arg-Gly-Asp (RGD) peptide sequence (18).  ECM proteins have been 
implemented as biomaterials to repair nervous tissue (19, 20) and increase compatibility of other 
materials interfacing with in the nervous system (21).  Our continuously increasing 
 3 
understanding of the role of ECM in axonal growth and regeneration has fueled many 
investigations of the repair efficacy of these particular materials (22). 
1.1.1 Laminin 
Laminin is a heterotrimeric glycoprotein consisting of alpha, beta, and gamma subunits that self-
assemble in a t emperature-, pH-, and concentration-dependent manner (2, 23).  As a major 
component of basement membrane ECM, laminin has frequently been shown to influence neurite 
outgrowth both in vitro (2, 24-26) and in vivo (25, 27-30). There are fifteen different types of 
laminins that have been identified thus far.  Plantman et al (12) showed that laminin-α1β1γ1 
(laminin-1 or laminin-111) promotes neurite outgrowth of adult DRG neurons in culture in the 
absence of growth factors.   Laminin is not a structurally robust ECM protein, and therefore quite 
suited for injection or as an adjunct in combination with other more supportive materials to 
increase cell growth (31-34) and differentiation (35). 
One group has shown that the structure of the laminin-1 polymer may be a determinant in 
its signaling pathways and/or efficacy. Certain structural configurations may induce regeneration 
and functional recovery when injected directly into the spinal cord following injury(30). 
1.1.2 Acidic Laminin Polymer 
In vivo, laminin has been shown to assemble in different structures depending on environmental 
cues (23).  U nlike some ECM molecules that require external factors for polymer formation, 
laminin is able to self-assemble, and readily does so in solution at room temperature (23).  
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Laminin-111 in particular has been shown to have the capability of assembling in different 
structural configurations in a pH-dependent manner (2).  These different structural configurations 
will be referred to here as acidic laminin (aLam, identifying the polymer structure assembled in a 
pH4 environment) and neutral laminin (nLam, identifying the polymer structure assembled in a 
pH7 environment).  Freire and colleagues showed that embryonic neurons grown on a substrate 
of aLam extend longer neurites than those grown on a substrate of nLam, without differences in 
number of adhered neurons or strength of cell attachment (2).  These data suggest that the 
configuration of laminin can alter its neurite growth-promoting capability.   
Laminin communicates with cells through binding to cell surface integrin receptors (36).  
The configuration of laminin could determine how it binds/activates integrins. Integrin activation 
regulates neurite outgrowth via formation and breakdown of focal adhesion complex and 
activation of Focal Adhesion Kinase (FAK) and mitogen-activated protein kinase 
kinase/extracellular signal-regulated kinase (MEK/ERK) signaling pathways leading to actin 
polymerization at the growth cone level and neurite extension (37). 
1.2 INTEGRIN RECEPTORS AND THE FOCAL ADHESION COMPLEX 
Integrin receptors are heterodimeric transmembrane proteins that consist of alpha and beta 
subunits, each with cytoplasmic tails that transmit information upon binding of a ligand to the 
cell. There are various integrins that mediate laminin-cell interactions (36). It has been shown 
that a crucial element for integrin dependent neurite growth is the β1 subunit (24, 38); α1β1 and 
α3β1 integrin receptors have specifically been implemented in laminin-111-mediated neurite 
growth in vitro (24, 26).  The Arginine-Glycine-Aspartic acid (RGD) motif is present in laminin 
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and involved in integrin binding.  Other motifs in laminin binding with different affinities to 
integrins result in a variety of cellular events (39). One of the cellular events cause by integrin 
signaling is the formation of the focal adhesion complex, which consists of a variety of proteins 
gathered together in a functional unit at the site of the cytoplasmic tails of the integrin receptors 
(Figure 1).   
 
 
Figure 1. Schematic of Focal Adhesion Complex with some of the key proteins highlighted 
 
 
One important protein within the focal adhesion complex is vinculin, which has been 
implemented in FAK autophosphorylation and actin polymerization specifically in the neuronal 
growth cone (40, 41).  This occurs when integrin receptors are activated and cluster together on 
the cell membrane in response to binding a ligand (42).  The ligand-receptor interaction can be 
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described as a dynamic equilibrium process where R is the receptor and L is the ligand and C is 
the receptor-ligand complex (Equation 1)(42). 
Equation 1 
         
Once receptors are activated and clustered and the focal adhesion complex is formed, 
there is a change in the association constant (Ka) of the ligand-receptor interaction (Equation 2) 
(16). The clustering of the receptors to form this complex results in a change in the probability of 
the ligand being bound to the receptor, thereby increasing the concentration of receptor-ligand 
complexes. 
Equation 2 
                             
 
Due to its natural role in promoting and guiding growth of axons in the developing CNS 
and adult PNS and the lack of effective axonal growth-promoting strategies when damage 
occurs, the potential of laminin to elicit axonal regeneration after nervous tissue injury is of 
clinically relevant interest.  Since aLam was found to be a better promoter of neurite extension 
than nLam, which is the typically used laminin polymer substrate in neuronal cultures, 
investigation of the mechanisms underlying aLam-induced axonal growth is of particular 
importance as it ma y reveal novel therapeutic targets that would support the development of 
materials that effectively promote axonal regeneration after nervous tissue damage.  Having a 
well-characterized in vitro model system for screening/evaluating materials for growth dynamics 
under live imaging would be a highly valuable tool.  
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1.3 MICROCONTACT PRINTING FOR LIVE IMAGING ASSESSMENT 
Microcontact printing (µCP) is a combination of soft lithography and stamp printing, most often 
performed with polydimethylsiloxane (PDMS) stamps made from etched glass or silicon master 
reliefs.  This technique was first utilized to pattern gold (43) and has since been utilized in many 
electronic and cellular biology applications.  One important benefit of using this technique is that 
the etched glass or silicon master relief allows for a high degree of pattern reproducibility.  A 
stamp can be used many times and easily be replicated in case some damage occurs.  T he 
concept behind µCP is that a particular material is used to create a reservoir of “ink” absorbed 
into the PDMS stamp (Figure 2).  This technique allows for µm level control over patterning of a 
substrate and, therefore, in biological applications, µm level control over the direction and 
surface to which cells will attach and migrate and/or grow.   
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 Figure 2 Microcontact Printing with 10% w/v SDS release layer 
 
 
 
Previously, using printing of a variety of ECM and non-ECM substrates, this technique 
has been shown to direct both neuronal and non-neuronal cell attachment and growth (44-48).  
An additional advantage is that this technique allows tracking of axonal growth cones because of 
the pattern-directed growth.  On a non-patterned substrate axons will grow indiscriminately in all 
directions, making accurate quantifiable comparisons of dynamic growth difficult.  The pattern-
directed growth of axons on stamped substrates, however, allows for easier tracking and thus 
measuring of growth speed and cell-cell interactions.   
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1.4 PERIPHERAL INJURY AND REPAIR 
In the US, up to 5% of people entering level 1 trauma centers have some type of damage to the 
peripheral nervous system leading to paralysis and/or neuropathic pain (5).  The axons injured in 
PNI derive from motor neurons located in the spinal cord ventral horn and/or sensory neurons 
located in the dorsal root ganglia.  Because PNI occurs frequently on the battlefield much of our 
current knowledge has been gathered in wars such as the American Civil War and the World 
Wars I and II (49-51).  Due to the high variety of causes and the fact that injured nerves may 
contain either motor or sensory axons  or both, the level of ultimate impairment (and recovery) is 
often unpredictable.  PNIs are most commonly categorized using the Seddon (49) or Sunderland 
(50) classification scheme.  Seddon classifies injuries into three categories termed “neurapraxia” 
(intact axon, loss of myelin or ischemia), “axonotmesis” (axon loss and variable stromal 
disruption) and “neurotmesis” (axon loss and complete disruption of endoneurial tubes, 
perineurium and epineurium) (49).  S underland classifies injuries in five degrees, the first of 
which is equivalent to Seddon’s “neurapraxia” and the fifth to “neurotmesis”.  In Sunderland’s 
classification scheme, the “axonotmesis” classification is further divided into second, third and 
fourth degree injuries depending on the degree to which the endoneurial tubes, perineurium and 
epineurium are intact or disrupted(50).   
While axons in the damaged peripheral nerve exhibit a relatively high intrinsic level of 
regeneration, the recovery of function is typically limited and largely dependent on the size and 
location of the defect.  Injuries causing greater than second degree severity typically require 
some surgical intervention (52).  Currently, the gold standard in surgical repair of moderate to 
long distance PNI is grafting of an autologous nerve, commonly the sural nerve, which connects 
proximal and distal nerve stumps and provides a Schwann cell-filled guidance conduit for 
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growth-promotion and guidance of severed axons (53).  T his gold standard approach remains 
suboptimal in that it invariably leads to loss of function at the donor site, and potential mismatch 
in graft size.  A n alternative approach is the use of allogeneic genic grafts but these require 
immune suppressors which may cause unwanted side effects.  T ime is of the essence when 
considering surgical treatments for PNIs.  If a motor nerve is damaged, the treatment window for 
axon regeneration and re-innervation is 18-24 months, after which time muscle atrophy is often 
an unsurmountable obstacle to functional recovery (52).  This therapeutic window is longer if the 
lesion is to a sensory nerve since their target end organs generally degrade much slower (52).  To 
maximize the overall level of functional recovery after PNI, treatments designed to encourage 
and/or enhance axonal regeneration should be implemented as soon as medically possible, 
especially with injuries involving motor axons.  
The use of biomaterials for peripheral nerve repair has received ample attention in the last 
decade.  It is a rapidly expanding field of pre-clinical and clinical research.  Due to the relative 
accessibility of many peripheral nerves, many strategies involving conduits have been 
investigated for their PNI repair potential.  Conduits become especially important in neurotmesis 
injuries where the guidance provided by the perineurium and epineurium has been disrupted.  
When one or more of these sheaths are left intact, as in axonotmesis injuries, injectable, growth-
promoting molecules/materials may be preferred as they do not  carry the risk of nerve 
compression associated with conduits. 
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1.5 SPINAL CORD INJURY AND REPAIR 
SCI produces an immediate and ongoing loss of nervous tissue often resulting in (thus far) 
untreatable loss of function, which has devastating personal and societal consequences. The most 
prevalent mechanism of SCI in humans is a contusion which typically presents in the formation 
of fluid-filled cystic cavities in the central spinal cord surrounded by a rim of spared white 
matter.  T hese anatomical incomplete contusions often result in complete loss of motor and 
sensory function.  A recent study conducted by the Dana and Christopher Reeves Foundation 
revealed that approximately 1.27 million people in the US alone are living with some type of 
paralysis as a result from SCI (54).  In the US, each year, there are approximately 12,000 new 
cases of SCI, which means that the group of people living with a spinal cord injury is steadily 
growing (54).  SCI results in physiological, sociological and psychological problems and a range 
of functional impairments, which are mostly dependent on the type, severity, and location of the 
initial injury.  Medical expenses and lifestyle changes associated with these injuries are costly to 
both the injured individuals and society.  Depending on t he level and severity of injury, the 
lifetime cost of SCI ranges between 0.5-3 million dollars per patient (54).  The personal and 
societal consequences of SCI drive the search for treatments that lead to biologically significant 
recovery of function (54, 55). 
There are three main mechanisms that are thought to contribute to recovery of function 
after a SCI: neuroprotection, rehabilitation, and regeneration. Neuroprotective approaches aim to 
limit the secondary loss of healthy nervous tissue which may lead to decreased overall loss of 
function and/or increased prospects for future repair strategies.  Neuroprotective approaches need 
to be initiated soon after injury to maximize the reparative effects. Rehabilitation, typically 
through physical therapy and/or electrical stimulation paradigms, aims to induce axonal plasticity 
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in spared axonal circuits that could lead to reorganization and increased functional connectivity.  
Regenerative approaches aim to promote axonal re-growth and re-connection with the original or 
new target neurons which could alone or in combination with targeted rehabilitative strategies 
lead to increased recovery of function.  The studies described in this thesis focus on an approach 
to promote axonal regeneration.  Axonal severance after SCI leads to interruption of signaling 
between the brain and spinal cord segments below the injury site and, ultimately, the periphery.  
Adult mammalian neurons retain the intrinsic ability, albeit to a limited degree, to regenerate 
their damaged axon.  However, the lack of (nervous) tissue, which could serve as a growth 
substrate, and the presence of axonal growth-inhibitory molecules, expressed by reactive 
astrocytes and in oligodendrocyte myelin debris, in and around the injury site, limit regeneration 
of axons and, consequently, their contribution to functional recovery.  Previous studies have 
shown that the introduction of axonal growth-promoting molecules/materials in the injured 
spinal cord may elicit axonal regeneration which in some, but not all, cases was accompanied by 
functional improvements. These partially successful studies are a major motivation for the 
development of novel more effective axonal regeneration-promoting biomaterials.  
1.6 GOALS OF THESIS 
The goals listed below guided the planning and design of each of the studies included in this 
Thesis.  The chapters in which the studies are described is listed in parenthesis.  All study results 
and future directions are discussed in the General Discussion section (Chapter 4). 
1) To develop and utilize a novel in vitro system to test the molecular and cellular 
mechanisms of aLam as a growth-promoting molecule (Chapter 2.1)  
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2) To employ microcontact printing and live imaging to create a system in which to 
study aLam’s effect on growth cone dynamics and glial cell involvement (Chapter 
2.2) 
3) To test the repair potential of aLam as an injectable regenerative therapeutic using an 
adult  rodent model of PNI (Chapter 3.1) 
4) To test the repair potential of aLam as an injectable regenerative therapeutic using an 
adult rodent model of SCI (Chapter 3.2) 
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2.0  SIGNALING MECHANISMS OF ACIDIC LAMININ-MEDIATED AXON GROWTH IN 
VITRO 
Previous studies showing that a substrate of aLam enhances neurite growth of embryonic 
cortical neurons in vitro (2), supporting the development of aLam as a therapeutic for nervous 
tissue repair.  At present, the mechanisms underlying the axon growth-promoting ability of aLam 
are unknown.  E lucidating these mechanisms will expand our current knowledge and possibly 
reveal novel targets supporting the development of more effective strategies to promote axonal 
regeneration and functional recovery after nervous tissue damage.  
 
2.0.1 In vitro model system 
 
The in vitro model systems typically used to investigate the potential of particular 
molecules to elicit and/or enhance neurite outgrowth contain embryonic neurons growing on a  
substrate of the molecule in question.  The main reason is that embryonic neurons, in contrast 
with adult neurons, retain their growth competence to a relatively large degree, allowing for a 
less demanding evaluation of the neurite outgrowth.  Previously, the effects of aLam on neurite 
outgrowth has been studied using embryonic neurons cultured on a substrate of aLam(1).  
However, the vast majority of injuries to peripheral nerves and the spinal cord occur in the adult 
and are ‘closed injuries’ with an intact epineurium and dura mater, respectively, which would be 
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best treated using injectable therapeutics.  So far, the effects of injectable, non-substrate, aLam 
on neurite outgrowth of adult neurons are unknown.  We have developed here a novel in vitro 
model system containing adult neurons with aLam presented as an unbound therapeutic to better 
model the specific circumstances of the majority of PNIs and SCIs (Figure 3).  In this novel 
culture model system, the neurons are grown on poly-d-lysine (PDL) which itself provides no 
support to neurite outgrowth.  We have used this model system to evaluate the effects of aLam 
on neurite outgrowth on t he molecular level, using antibody blocking and SDS-PAGE and 
Western Blot, and the cellular level, using live cell imaging and immunocytochemistry (Chapter 
2.1).  In order to elucidate what occurs during an active growth period, a microcontact printed 
pattern of PDL was tested in its ability to guide neuronal outgrowth and allow for a more 
rigorous and clear visualization of the dynamic growth process (Chapter 2.2). 
Figure 3 In vitro model system  
With this model we enabled investigation of the effects of different laminin structures 
(aLam and nLam) on integrin binding and activation and neurite growth.  This provided novel 
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insight into the testing of signaling capability of self-assembling ECM molecules in an 
environment where they are not acting as a primary substrate for cell attachment.  This system 
can potentially be used to differentiate between factor-like signaling and substrate-signaling of a 
variety of ECM molecules/binding motifs that have so far only been investigated as a substrate 
for neurons.  T his is a new and innovative in vitro approach to studying ‘substrate-like’ 
molecules that are being investigated as injectable treatments following spinal cord and 
peripheral nerve injury.   
2.1 ACIDIC LAMININ POLYMER AND INTEGRIN-MEDIATED SIGNALING 
2.1.1 Introduction 
Regeneration of axons (or lack thereof) following a traumatic injury to the nervous system is a 
widely studied, yet somewhat poorly understood phenomenon.  T here are both intrinsic and 
extrinsic factors that contribute to the anatomical and physiological outcome.  Studies of intrinsic 
factors are mostly focused on t he intracellular changes occurring naturally with age, or as a 
consequence of damage, including gene expression, protein transport and physiological 
properties.  E xtrinsic factors contributing to the level of endogenous axon regeneration in 
damaged nervous tissue include invasion and activation of inhibitory macrophages and 
microglia, scar formation, myelinating glial state changes, availability of growth factors and the 
breakdown in both structure and function of the extracellular matrix (ECM). ECM provides 
important scaffolding for cellular growth as well as a signaling ligand for membrane-bound 
receptors.  T hese cell adhesion receptors affect gene expression for growth, direction and 
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apoptotic signaling cascades within the cells. Different components of the ECM typically define 
the niche in which a cell resides.  M uch of CNS development is driven and arrested through 
ECM (and other non-matix extracellular signaling molecules)-receptor interactions.  The integrin 
family of receptors, specifically, interact with many of the different ECM proteins including 
fibronectin, collagen and laminin (56).  In order to evaluate the mechanisms of structurally 
different laminin polymers for axon outgrowth, the in vitro experiments described here have 
been purposefully designed to gather information about its potential for use as a s ignaling 
molecule interacting with adult, terminally differentiated neurons.  We will test the hypothesis 
that aLam signals through integrin receptors in order to promote the neurite outgrowth 
competence of adult neurons in vitro. 
2.1.2 Materials and Methods 
2.1.2.1 Reagents 
aLam and nLam: Laminin-111 (Invitrogen, 1mg/ml in saline) was diluted to a final concentration 
of 50μg/ml in either a Tris buffer (20mM, pH 7, nLam) or Sodium Acetate buffer (20mM, pH 4, 
aLam) as described in (2). ALam or nLam was suspended in culture medium for cellular 
exposure. 
Dissociation and Culture Media: Dulbecco’s Modified Essential Medium (DMEM) + 10% Fetal 
Bovine Serum (FBS) + 1% Penicillin Streptomycin (Pen/Strep). 
2.1.2.2 Neuron cultures 
DRG dissection and culture protocol were modified from Malin et al (57) for use with adult rat 
neurons cultured on poly-D-lysine.  Dorsal root ganglia (DRG) neurons were harvested from the 
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L3-L5 spinal section of adult female Sprague-Dawley rats (200-250 g) under deep sedation of 
Ketamine (90 mg/kg)/ Dexmedetomidine (0.75 mg/kg) (IP) to maintain the integrity of the 
neurons.  Laminectomy was performed to expose L1-L6 spinal cord and the L3-L5 DRG pairs (6 
ganglia total) were dissected (Figure 4).  Individual ganglia were thoroughly cleaned from blood 
and nerve fragments and dissociated enzymatically (10 min papain (40 units/mL, Worthington, 
#3126) followed by 20 min collagenase type II (1580 units/mL, Worthington, #4176)/dispase 
type II (8.5 units/mL, MB, #165859) under agitation at 37 ºC) and mechanically (15 x trituration 
in HBSS (-Ca -Mg) with fire-polished glass pipette, centrifuge at 4.5 min, 3000 g to pellet 2x). 
The cells were transferred to pre-warmed culture medium (37ºC) and 100 uL of cell suspension 
was added to each poly-d-lysine (PDL, 100 μg/mL, Millipore, #A-003-E) coated 15 mm glass 
cover slip (Ted Pella, #26021) in a 12-well plate and placed into a humidity controlled incubator 
(5 % CO2/37 °C). After 2 h, neuronal cultures were treated with either culture medium alone or 
culture medium containing 10 % aLam or nLam (50µg/mL), followed by 24 h incubation. 
Cultures were then prepared for either immunostaining or gel electrophoresis. 
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Figure 4 Schematic of rat spinal cord with dorsal root ganglia (DRGs). Location of L3-L5 ganglia lies 
directly rostral to iliac crest 
2.1.2.3 Immunostaining and Axon Length Quantification 
Cell cultures were fixed with 4 %  paraformaldehyde (PFA) for 10 m in at room temperature. 
Nonspecific binding sites on fixed cells were blocked using 5% Normal Goat Serum (NGS) and 
permeablized with 0.3 % Triton in .01M Phosphate Buffered Saline (PBS) for 30 m inutes at 
room temperature.  C ells were then incubated with primary antibodies diluted in blocking 
solution for either 2 h a t room temperature or up to overnight at 4 °C  (Table 1).  F luorescent 
secondary antibodies diluted in 0.01 M  PBS (Alexa Fluor®, life technologies) (Table 1) were 
added for 1 h a t room temperature, followed by DAPI counterstaining and coverslips were 
inverted onto microscope slides. Axon lengths were determined using a Zeiss Axio Observer 
inverted fluorescent microscope with Zeiss Plan Apochromat objective (20 x air, NA 0.8), and 
Neurolucida (MBF Bioscience) software.  Slides were relabeled to blind experimental conditions 
and the 10 ne urons with the most substantial growth from each coverslip (minimum 3 
coverslips/condition) were identified for tracing and quantification.  Each experiment contained 
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3 biological replicates and at least 3 technical replicates. Graphs are pooled results of all cells 
analyzed (minimum 90 cells/group). 
2.1.2.4 Integrin Blocking  
Cells were harvested and plated as described above.  Following plating, cells were incubated at 
37 °C and 5 % CO2 with integrin-blocking antibodies at a concentration of 20 µg/mL (see Table 
1) in culture medium for 2 h. Then, fresh culture medium alone or containing aLam or nLam was
added to each well, and the incubation continued for 24 h. The cells were then prepared for either 
immunocytochemistry or protein gel electrophoresis. PDL was chosen as a cell substrate for all 
in vitro experiments because it binds neurons non-specifically, so that initial cell adhesion did 
not confound the evaluation of integrin-laminin interactions. 
2.1.2.5 Electrophoresis and Western Blot 
In order to obtain enough protein for detection, cells from six pairs of DRGs (L1-L6)/2 rats were 
dissected and cultured for 24 h as described above.  The cells were then trypsinized using manual 
agitation for 12 min, rinsed, and lysed using PMSF-RIPA buffer.  T he proteins from the cell 
lyses were combined with Laemmli Buffer (3:1) in boiling water for 5 min, placed on wet ice 
and separated by denaturing polyacrylamide gel electrophoresis (SDS-PAGE) (125 V, 75 min) 
using Novex® precast Tris-glycine gels (life technologies, EC60255BX5). A total of 15 µL 
lysate+buffer was loaded per well and transferred overnight at 4 °C to nitrocellulose membranes 
(100 V).  
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2.1.2.6 Protein Staining and Visualization 
Nonspecific binding sites of proteins on the membranes were blocked using 1 x TBS-T + 5 % 
blocking (Bio Rad, #107-6404XTU) 1 h at room temperature. Membranes were then incubated 
with primary antibodies diluted in blocking solution (see Table 1) for 1 h at room temperature 
followed by overnight at 4 ˚C. After rinsing, membranes were exposed to Horseradish 
Peroxidase (HRP)-conjugated secondary antibodies for 1 h at room temperature.  Protein bands 
were visualized using enhanced chemiluminescent (ECL) substrate (SuperSignal West Femto, 
ThermoScientific, #34095) followed by 10 s ec exposure to ECL Hyperfilm and developed. 
Quantification was performed using ImageJ software gel analysis tool (58).  
Table 1 Working Concentrations of Primary and Secondary Antibodies 
Experimental Procedure Antibody Specifications Working Concentration 
(μg/mL) 
Immunocytochemistry Anti-ß-III Tubulin (purified rabbit monoclonal; Covance, 
MRB435P) 
0.5 
Immunocytochemistry Alexa Fluor 488 (α-rabbit, IgG; Molecular Probes, A11008) 0.4 
Antibody blocking Anti-α1 Integrin (rabbit polyclonal;  Antibodies-online, 
ABIN343462) 
20 
Antibody blocking Anti-α3 Integrin (mouse monoclonal; BD, 611044) 20 
Antibody blocking Anti- α5 Integrin (rat monoclonal; antibodies-online, 
ABIN135245) 
20 
Antibody blocking Anti- α6 Integrin (CD49f, purified rat monoclonal; BD, 
555734) 
20 
Western Blot Anti-GADPH (rabbit polyclonal; Sigma, G9545) 0.125 
Western Blot Anti-ß-III Tubulin (purified rabbit monoclonal; Covance, 
MRB435P) 
1 
Western Blot Vinculin (mouse monoclonal; Sigma, V9264) 0.1 
Western Blot Anti-α3 integrin (mouse monoclonal; BD, 611044) 0.5 
Western Blot Anti-α1 Integrin (rabbit polyclonal;  Antibodies-online, 
ABIN343462) 
1 
Western Blot Goat α-rabbit (IgG, HRP; Invitrogen, G21234) 0.2 
Western Blot Goat α-mouse (IgG, HRP; Invitrogen, G21040) 0.2 
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2.1.2.7 Statistical Analysis 
Differences in outgrowth data was tested using the Kruskal-Wallace test for nonparametric data 
in SPSS software package (SPSS version 21, IBM).  Data, as expected failed homogeneity of 
variance assumption required for standard ANOVA testing (medium only group had very low 
variance as most cells grew very little or not at all, while other groups had some cells with very 
limited and others that had extensive outgrowth).  All other measurements satisfied assumptions 
and therefore F-statistic (ANOVA) was calculated using SPSS statistical software package. 
Significance was set at ≤ 0.05. 
2.1.3 Results 
2.1.3.1 aLam promotes neurite growth from adult DRG neurons in vitro better than nLam 
No difference in neuronal attachment was detected between groups (p > 0.05, data not shown) 
with all cells plated on PDL coated glass coverslips.  Photomicrographs are presented in Figure 5 
to illustrate the outgrowth of the neurons under the various conditions.  Q uantification 
demonstrated that neurons presented with aLam exhibited significantly greater neurite outgrowth 
(p < 0.001) than those presented with nLam or medium only (Figure 5). 
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Figure 5 Neuronal Outgrowth Profiles.  Graph: Box Plot of median neurite outgrowth per group after 
24hr incubation, Independent-Samples Kruskal Wallis test significance <.001 between groups.  Images: Acidic 
laminin (aLam), Neutral laminin (nLam), Medium alone (βtubulin-III (green), DAPI (blue); scale bar = 50µm.  
Note: Brightness of all color channels equally enhanced to better visualize outgrowth). 
2.1.3.2 aLam and nLam exhibit differential interactions with α1 and α3 integrins 
We used integrin blocking to study laminin-cell communication.  Immunocytochemistry 
for α1 and α3 integrins revealed that both receptors are present on the neurons in our cultures 
prior to exposure to laminin (Figure 6).  With any of the used antibody combination, differences 
in cell adhesion of the neurons were not observed (p > 0.2, data not shown).   
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With blocking of α1 integrin only, the growth-promoting capabilities of aLam, but not 
nLam were unaffected.  T he average measured outgrowth of cells exposed to aLam was 
unchanged following α1 integrin blocking relative to unblocked aLam control (p > 0.3), while 
that of cells exposed to nLam was significantly decreased (p < 0.01) (Figure 6). 
With blocking of α3 integrin only, the neurite growth responses did not significantly 
decrease in aLam or nLam groups relative to unblocked controls (p > 0.05).  On the other hand, 
blocking of both α1 and α3 integrin resulted in a significant decrease in outgrowth of neurons in 
aLam (p < 0.001) and nLam (p < 0.01) (Figure 6).   
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Figure 6 Neuronal Outgrowth Profiles after Antibody Blocking.  Images: DRG neurons plated on poly-
D-lysine with antibody blocking of α1 integrin(first row), α3 integrin (second row) and α1+ α3 integrins (third row),   
+aLam added to culture (first column), +nLam added to culture (second column). (βtubulin-III (green), DAPI (blue); 
scale bar = 50µm); Note: brightness of all color channels equally enhanced to better visualize outgrowth in images.   
Graphs: Mean neurite outgrowth (µm) per each condition.  F or aLam condition * denotes p < 0.001; for nLam 
condition * denotes p < 0.01, # denotes p < 0.05. 
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To test the specificity of the α1 and α3 integrin involvement in laminin-mediated neurite 
outgrowth, additional controls for the blocking experiments that included α5 (a non-laminin 
associated integrin) and α6 (a non-growth laminin-associated integrin) were similarly evaluated 
with immunostaining/axon quantification analysis. The results showed that neither α6 nor α5 
blocking resulted in significant decrease in outgrowth (p >0.05) under either experimental 
condition (data not shown), suggesting that aLam and nLam signal their neurite growth activity 
through α1 and α3 integrins. 
2.1.3.3 Blocking α1 integrin leads to laminin structure-dependent changes in the relative 
expression of α3 integrin  
Protein electrophoresis and western blotting were performed on cell lysates from integrin 
blocking experiments to calculate the relative protein concentrations.  We confirmed that the 
levels of glyceraldehyde 3-phosphate dehydrogenase (GADPH) were similar between groups, 
allowing it to  be used as a standard to compare integrin levels (Figure 7).  In the unblocked 
condition, there are similar relative expression levels of α1 and α3 integrins in the presence of 
either aLam or nLam (Figure 7A, C).  When α1 integrin was blocked, followed by exposure to 
aLam, cells exhibit a relative increase in the expression of α3 integrins (Figure 7, D).  When α1 
integrin was blocked, followed by exposure to nLam, no change in α3 integrin expression was 
detected (Figure 7, B).   
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Figure 7 Increased α3 Integrins Expression After α1 Block.  A) Relative α3 integrin protein levels from 
unblocked DRG cell lysates exposed to nLam. B) Relative α3 integrin protein levels from cell lysates where α1 
integrin has been blocked followed by exposure to nLam. C) Relative α3 integrin protein levels from unblocked 
DRG cell lysates exposed to aLam. D) Relative α3 integrin protein levels from cell lysates where α1 integrin has 
been blocked followed by exposure to aLam. 
2.1.3.4 The presence of aLam increased relative amounts of Vinculin 
Total amounts of vinculin in cultures containing aLam, nLam or media alone were evaluated 
using SDS-PAGE and Western Blot.  These semi-quantitative results revealed relative increases 
in vinculin protein concentration compared to GADPH levels. The highest level of vinculin was 
found in neurons exposed to aLam, while the lowest levels were found in neurons exposed to 
medium only (Figure 8).   
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Figure 8 Vinculin Protein Expression Levels.  Relative vinculin protein levels in cell lysates from DRG 
cultures exposed to aLam are greater than nLam or medium alone. 
2.1.4 Discussion 
Laminin is known for its effects on neural outgrowth in vivo during development and as a 
substrate for attachment in neuronal cultures in vitro.  S o far, the effects of laminin as an 
unbound signaling molecule for neurite outgrowth in vitro have not been investigated.  In the 
present in vitro study we demonstrate that: 1) aLam and nLam can act as a signaling molecule to 
promote neurite outgrowth of adult neurons; 2) aLam is a significantly stronger promoter of 
outgrowth of adult neurons in vitro than nLam; 3) aLam and nLam convey their actions 
differentially through α1 and α3 integrins; 4) aLam, but not nLam, causes upregulation of α3 
integrins under blocking of α1 integrin; 5) aLam causes an upregulation of vinculin.  O ur 
findings support the notion that unbound a Lam promotes enhanced outgrowth in vitro by 
increasing integrin activation leading to enhanced actin polymerization and neurite growth.  The 
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data from this study confirm the use of aLam as a signaling molecule to promote neurite 
outgrowth in vitro and its potential to affect axon regeneration in damaged nervous tissue.   
 
We demonstrate that laminin polymers can act as a signaling molecule to promote neurite 
outgrowth of adult neurons in vitro, and that aLam, is a superior to nLam in growth promotion 
signaling. To our knowledge this is the first demonstration that laminin polymers act as a 
signaling molecule enhancing the neurite outgrowth competence of adult neurons. The finding 
that aLam is a stronger promoter of neurite outgrowth than nLam agrees with earlier 
observations made in an in vitro model system containing embryonic neurons on a substrate of 
the two laminin polymers (2). However, our novel model system introduces two important 
features which significantly enhance the clinically relevance of the potential use of laminin 
polymers as nervous tissue repair-supporting molecules. One, we employed adult neurons which 
is an important and clinically relevant expansion of our current knowledge that aLam enhances 
neurite outgrowth of embryonic neurons (2), because the majority of nervous tissue injuries 
occur in adults. Two, we presented unbound, free, laminin polymers to the cultured adult 
neurons, rather than as a bound substrate, which is clinically relevant because most injuries to 
peripheral nerves and spinal cord are ‘closed injuries’ that prefer the use of injectable 
therapeutics. Together, the demonstrated enhancement of the neurite growth-promoting 
competence of cultured adult neurons of injectable laminin polymers open new avenues for using 
the development of effective strategies for repair of damaged nervous tissue.  
 
We used molecular biology techniques to start understanding how aLam supports the 
neurite outgrowth abilities of neurons.  Previous studies have suggested that laminin-111 signals 
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its growth promoting effects though α1 and α3 integrins, although there are a variety of integrin 
receptors for laminin.  Our results revealed that both aLam and nLam signal their neurite growth-
promoting actions also through the α1 and α3 integrins.  The use of these two receptors appears 
to be specific for these polymers because we also showed that α5 integrins, which do not bind 
laminin, and α6 integrins, which bind laminin but is not primarily involved in neurite outgrowth, 
were not involved in aLam and nLam-mediated actions on ne urite outgrowth in our model 
system.  
If both types of laminin polymers signal through the same two receptors, how can then 
their total effect on ne urite outgrowth be different?  O ne possible reason is that the different 
polymers have different effects on the presence of the integrins on the cell surface.  In general, 
an increase in the total amount of integrins would cause a stronger output.  O ur data did not 
support the idea that aLam would elicit an increase in the total amount of either α1 or α3 
integrin.  Interestingly, our integrin blocking experiment demonstrated that aLam, but not nLam, 
causes a relative increase in α3 integrin when α1 integrin was blocked.  The role of this up 
regulation of α3 integrin by aLam, under non-physiological circumstances, is unknown but may 
indicate a co mpensatory effect to preserve the overall outgrowth effect.  T his may be of 
importance for future applications under conditions where neurons do not express or only 
express the α1 integrin to a low degree.  This finding enhances the overall impact of aLam as a 
neurite growth-promoting molecule.  Future studies aiming at evaluating neural selectivity of the 
growth-promotion elicited by aLam are needed to further elucidate this phenomenon. 
An alternative, or complementary, reason for our observed differential effects of the 
polymers on neurite outgrowth even though they bind the same integrin receptors, is differential 
levels of activation.  Upon ligand binding to integrins, intracellular events initiate clustering of 
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various proteins forming a focal adhesion complex. One of the crucial protein components of this 
complex is vinculin and our data demonstrate that the expression of this protein was increased in 
the presence of aLam.  T hese findings indicate that aLam causes an increase in integrin 
activation which could lead to enhanced actin polymerization and neurite outgrowth.         
The knowledge of multi-integrin binding of the polymers resulting in enhanced neurite 
growth is important for the future development of synthetic biomaterials to be employed in 
nervous tissue repair strategies. Based on t his, such biomaterials could be designed to mimic 
aLam in its potential to elicit growth by enhanced formation of the focal adhesion complexes via 
co-binding α1 and α3 integrins.  Another way to interpret this finding is to consider the potential 
of laminin in this configuration to have a complementary binding site, as is the case in 
fibronectin (59).  Possibly, such a structural configuration could bring two integrin-binding 
ligands into close proximity, allowing for different binding affinity or activation state.  If this is 
the case, the specific structure and presentation of binding ligands relative to one another is 
essential to elicit outcomes.  F uture studies testing this hypothesis by presenting these two 
peptides in close proximity at an optimal distance may further improve effects on ne urite 
outgrowth. 
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2.2 MICROCONTACT PRINTING OF POLY-D-LYSINE FOR LIVE IMAGING 
ANALYSIS OF AXON GROWTH 
2.2.1 Introduction 
Microcontact printing (µCP), a method for patterning substrates on a micron level accuracy, is a 
useful tool for creating patterns for directed growth on specialized culture dishes or coverslips 
specifically designed for use with live imaging.  This technique is especially enticing because it 
can utilize many different substrates, including growth inert ones, like poly-d-lysine, for the 
targeted evaluation of growth-promoting molecules delivered in the media.  T his gives it an 
advantage over other growth-directing tools such as microfluidic devices, which require a 
minimal amount of growth-promotion within the substrate in order for axons to enter the 
designated chambers.  When we attempted to use microfluidics for evaluation of unbound 
laminin with a PDL substrate, all growth remained within the soma reservoir and little to none 
was not drawn into the axon chambers, this phenomenon did not occur when laminin was used as 
a substrate.  For our purposes here, developing this system into a successful tool for use with 
PDL and live imaging of neurite growth could provide valuable information not otherwise 
readily available.   
In this study, we utilize the µCP technology to guide neurite outgrowth of adult neurons 
in order to track and quantify additional aspects of growth mediated by laminin polymers using 
live imaging and differential interference contrast (DIC) microscopy.  
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In this chapter we will test the hypothesis that utilizing µCP patterned PDL substrates 
will allow for neuronal tracking to evaluate aLam elicited growth dynamics, including secondary 
interactions with glial cells and an increase in growth speed. 
2.2.2 Materials and Methods 
2.2.2.1 Reagents 
Culture Medium:  The culture medium contained 25 mL Neurobasal®-A (Gibco) + 0.5 mL B-27 
+ 0.5 mM Glutamine + 1 % Penicillin Streptomycin (Pen/Strep). 
Imaging Medium: The medium used for imaging contained the culture medium + 25 mM 
HEPES. 
aLam and nLam: Laminin-111 (Invitrogen, 1 mg/ml in saline) was diluted to a final 
concentration of 50 μg/ml in either a Tris buffer (20 mM, pH 7, nLam) or Sodium Acetate buffer 
(20 mM, pH 4, aLam) as previously described (2) and as used on our in vitro investigation of the 
underlying mechanisms (see Chapter 2.1). ALam or nLam were suspended in culture medium 
before added to neuronal cultures. 
2.2.2.2 Preparing culture dishes 
Using a bench top drill press equipped with a ½ inch hollow bit, 35 mm culture dish was fixed 
onto a stage and a hole drilled in the center of the dish. Edges were smoothed to ensure a clean, 
flat surface for attachment of a 25 mm PDMS spin-coated glass coverslips. The coverslips were 
attached using a thin layer of PDMS along the edge of the drill hole on the inside of the dish and 
gently pressing it to ensure a seal is made.  Dishes are then cured for 24 h at 65 ºC.  To sterilize, 
dishes with attached coverslips are treated in a UVO (UV light and Ozone gas) cleaner for 15 
min prior to stamping.  
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2.2.2.3 Alternate coverslip preparation 
As an alternate to the culture dishes, we prepared 40mm PDMS spin-coated coverslips with µCP 
of patterned PDL for use in a Bioptechs closed chamber system (Bioptechs, FCS2/FCS3) live 
imaging chamber specifically designed for these size coverslips.  Coverslips were prepared in the 
same manner as the 25mm ones described in 2.2.2.2.  On these coverslips, cells were allowed to 
attach and grow for 24 h prior to transfer into the chamber followed by 12 h of  live imaging.  
This system was implemented because it allows for the objective to access a greater area of the 
coverslip, which included the entire stamped area.  
2.2.2.4 Microcontact Printing of Poly-D-lysine 
Microcontact printing of poly-D-lysine was done on culture dishes or coverslips (section 2.2.2.2 
and 2.2.2.3).  Stamps were premade and generously provided by Dr. Feinberg’s lab at Carnegie 
Mellon University. The pattern used was 20 µm thick lines of PDL at 30 µm intervals.  PDMS 
stamps were sonicated pattern side up in 10 % W/V Sodium Dodecyl Sulfate (SDS) for 30 min 
(SDS was used as release layer to enhance transfer of PDL from stamp to coverslip (60)), then 
transferred immediately to a sterile culture hood.  Stamps were dried with a nitrogen air gun and 
coated with 200 µL of 200 µg/mL PDL.  Once pipetted onto stamp, maximum coverage was 
ensured by gently dragging the edge of the pipette tip over the PDL, using the surface tension to 
expand droplet to each corner of the stamp.  Stamps with PDL were kept under sterile conditions 
at room temperature for 1 h t o allow adequate “inking”.  After this incubation period, stamps 
were rinsed twice in sterile diH2O and dried with nitrogen air gun.  Stamps were then inverted 
onto PDMS-coated coverslips directly over the center hold drilled into the culture dish and 
gently tapped using sterile forceps to ensure complete contact.  After 5 min, they were gently 
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removed without disrupting the pattern, and either re-inked or stored for future use.  S tamped 
dishes were filled with sterile diH2O, wrapped in Parafilm and stored at +4 ºC until use.  
2.2.2.5 Cell Culture and Live Imaging 
DRG neurons were dissected and prepared for culture as described previously (see 2.1.2.2 
Neuronal Cultures).  Prior to plating, cells were run through a 50 µm cell strainer to remove 
any connective tissue debris.  Just prior to use, µCP dishes were treated with 1 % Pluronics F-27 
solution for 5 min followed by 3 washes with sterile diH2O. Then all fluids were removed and 
200 µL of strained cells were plated on the µCP dishes, incubated for 2 h to allow attachment, 
and then filled with culture media and incubated for 10 h (37 ºC, 5 % CO2) to allow initial 
growth to occur.  Cultures were then treated with 25 mM HEPES and imaged using Differential 
Contrast Imaging (DIC) on a Nikon T2 Live cell imaging system with an atmospheric and 
temperature-controlled stage (37 ˚C, 5 % CO2) using a Nikon CFI Plan Fluor objective (40 x oil, 
NA 1.3) (for schematic of set-up see Figure 9).  Fifteen different XY coordinates were taken at 
each time point, 10 msec exposure time, 10 min time between acquisitions, for a duration of 12 
h.  Medium containing either aLam or nLam was added at the 1 h time point.  I mages were 
acquired using a P hotometrix camera and videos were collected and processed using NIS 
Elements 4.0 software. 
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Figure 9 Schematic of modified culture dish 
2.2.2.6 Statistical Analysis 
Factorial ANOVA is used to evaluate growth speed, neurite length, and number of neuron-glia 
interactions between aLam and nLam groups. Differences between groups were considered 
significant at p < 0.05. 
2.2.3 Results 
2.2.3.1 Microcontact Printing with SDS release layer is an efficient way of creating 
patterned PDL for axonal guidance in culture 
Prior to live imaging, stamped dishes were evaluated with and without cultured cells and stained 
for visualization. Results indicated that stamping technique was: a) effectively transferring PDL 
in the desired pattern, and b) the patterned lines had sufficient width to allow for cell attachment 
and directional growth.  Figure 10 illustrates a stamped pattern with and without cell attachment. 
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The PDL concentration of 200 µg/mL proved to be optimal for stamping and the 20 µm width of 
the PDL pattern allowed for cell attachment and directional outgrowth.  
Figure 10 Image of poly-D-lysine stamp on PDMS coated coverslip.  (A) Coverslip without cells (goat α 
mouse AF 555; 1:500); (B) with neurons attached (βIII tubulin(red)/S100(green)/DAPI(blue)), arrows denote 
direction of pattern, scale bar=50µm. Note: Images artificially brightened for better visualization. 
2.2.3.2 Neurons did not adhere strongly enough for live imaging outgrowth assessment 
When our cultures were transported for live imaging, there was a noticeable trend that the 
cells were not remaining adherent and there were significantly less cells observed under live 
imaging conditions than initially observed under normal culture conditions.  Cells that remained 
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attached did not achieve significant levels of outgrowth regardless of whether we implemented 
modified culture dishes (Section 2.2.2.2) or alternative stamping (Section 2.2.2.3) methods 
(Figure 11). 
Figure 11-Live Imaging aLam.  12h of live imaging on modified culture dish with stamped PDL revealed 
little adhesion and movement (either growth or direction).   
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2.2.4 Discussion and future studies 
Our results here suggest that microcontact printing holds potential for directed neuronal cell 
grow using a growth neutral substrate (PDL) in culture.  DRG neurons and glial cells were able 
to adhere and neurons extended neurites along stamped PDL.  However, some aspects of this 
method could benefit from further optimization.  D istance between stamped lines may be 
extended to the point that glia cells are unable to bridge them.  Using the current pattern, glia 
appear to have formed bridges between substrate lines, which allowed neurites to grow both in 
phase with the stamped substrate, as well as perpendicular to it.  
When attempting to translate from still post-fixation figures to live imagine, we made 
some interesting observations.  Relatively few viable cells remained on the pattern.  O riginal 
modified imaging dishes restricted the area of focus so that the objective had access to only a 
small percentage of the total stamped area.  This was our initial motivation for utilizing the 
alternative coverslip stamping preparation, which allowed the objective to capture the entirety of 
the stamp.  T herefore we were able to determine that cells were consistently not achieving a 
sufficient level of adherence required for live imaging at any part of the stamped substrate. 
Increasing the width of stamped lines from 20µm to 50µm may encourage greater cell adhesion 
to the pattern. In spite of the limited overall adherence, cells that were captured, using either of 
our methods (dishes or Bioptechs), remained viable for the entire 12h i maging period.  T his 
finding shows that we can successfully image neurons over this period of time using the current 
protocol without loss of viability.  
In order to assess growth dynamics associated with aLam treatment in culture, some 
future design steps may be considered, 1) evaluate different stamped patterns including patterns 
with wider substrate lanes (some DRG cell bodies can reach up t o 50µm in diameter) for 
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stronger soma attachment and wider lanes between growth lane to discourage glial bridge 
formation; 2) optimize timing of imaging so that cells have additional time for stronger 
adherence and outgrowth initiation and implement measures to minimize movement of dishes 
during transport that could initiate sheer force, breaking cell adhesion bonds.  Although 12 h was 
calculated as the optimal imaging time in order to visualize some initial outgrowth to track, this 
was optimized using PDL coated, not stamped dishes, stamped dished appear to require addition 
time to achieve similar level of outgrowth. With the restricted attachment substrate, neurons 
appear to interact less with one another as well as with glial cells.  We could potentially 
overcome some of this by culturing the neurons utilizing a higher plating density.  Overall, this 
technique shows promise for analyzing real-time growth dynamics of cultured adult neurons over 
long periods of time. 
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3.0  TESTING OF ACIDIC LAMININ FOR NERVOUS TISSUE REPAIR 
Our data from chapter two suggests that DRG neurons exposed to aLam in vitro exhibit 
increased growth competence resulting in longer neurites than those in nLam or culture medium 
only without laminin polymers. In this chapter, we will test whether or not aLam has similar 
effects on neurons in vivo and whether this would result in increased repair. DRG neurons in vivo 
are referred to as ‘pseudounipolar cells’ because they have a single axon that splits shortly after 
leaving the cell body with one branch projecting out into the periphery through the peripheral 
nerve while the other branch projects through the dorsal root towards the spinal cord where they 
either terminate in the grey matter of the segment of entry or course through the dorsal columns 
towards the dorsal column nuclei in the brainstem. To test whether the in vitro actions of aLam 
can be translated into in vivo nervous tissue repair, we have elected two models of nervous tissue 
injury that represent each of the two environments, PNS and CNS, in which the bipolar DRG 
neurons extend their axons.  It is well known from the literature that these two environments 
differ in how they respond to an injury and to what degree they support axonal re-growth. By 
considering both types of environments we can more accurately evaluate the potential of aLam 
as a treatment for nervous tissue repair.  W ithin these two environments, we chose clinically 
relevant models of ‘closed’ injuries that would allow injection of the laminin polymers.  In the 
periphery, we utilized a moderate crush injury model (Seddon classification level 
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axonotmesis/Sunderland forth degree-epineurium intact) (49, 50).  C entrally, we utilized a 
contusion injury, which is the most common mechanism of SCI in humans (54). 
For both in vivo studies conducted, all animal care and procedures were done in 
accordance with approved guidelines set by the National Institutes of Health and the United 
States Department of Agriculture and monitored by the University of Pittsburgh Institutional 
Animal Care and Use Committee, protocol approval #12050540.  A ll rats were housed within a 
double-barrier animal facility with 12 h/12 h light/dark cycles and continuous access to fresh air, 
food, and water. 
3.1 ACIDIC LAMININ FOR PERIPHERAL NERVE REPAIR 
3.1.1 Introduction 
The peripheral nervous system is defined as the nerves and ganglia that lie outside of the brain 
and spinal cord.  This environment differs from the CNS in both its glial population (Schwann 
cells and Satellite cells versus astrocytes, oligodendrocytes, and microglia) and access to blood 
supply and nutrient (lack of a blood - peripheral nerve - barrier versus a blood - brain (spinal 
cord) - barrier).  S chwann cells play an important role in the relative larger regenerative 
competence of damaged axons in the PNS (61). Upon injury, Schwann cells dedifferentiate into 
nonmyelinating cells that, along with macrophages, clean up damaged myelin and other cellular 
debris, produce ECM, secrete numerous growth factors, and form Bands of Bungner, which all 
together create conducive regeneration pathways for severed axons.  Following successful axon 
regeneration, Schwann cells differentiate back to their mature state and myelinate the new 
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processes (61). One of the ECM components produced by Schwann cells is laminin which in the 
PNS plays an essential part in the regeneration response.  It was shown that in mice in which 
Schwann cells were genetically altered to not produce and secrete laminin the regeneration 
response was significantly impaired following a sciatic crush injury(62).  DRG neurons express 
α1 and α3 laminin-binding integrins at the surface of their cell bodies and growth cones in 
culture as well in vivo (Figure 10). 
Figure 12 Integrin Expression of DRG cells in culture and tissue. A) α1 integrin expression in culture at 
the cell body and growth cone (arrow) βtubulinIII (red), alpha1 (CD49a) (green).  B) α3 integrin expression in 
culture at the cell body and growth cone (arrow).  βtubulinIII (red), alpha3(CD49c) (green). C. Integrin expression 
in DRG tissue slice (CD49a (red), CD49c (green), DAPI (blue); Scale bar=100µm) 
C
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Combined with our in vitro findings, this information implies that aLam could support axon 
regeneration following a moderate crush injury of the peripheral nerve.  Injuries to the peripheral 
nervous system are common and can have a devastating impact on a person’s daily life.  One 
possible treatment  is to promote and/or enhance axon regeneration using extrinsic signalling 
cues administered following injury,  Using Seddon’s method of nerve damage characterization, 
we focus on a n injury model of axonotmesis because it represents an injury that typically 
requires some type of intervention for recovery, but does not require an implantable guidance 
conduit because the epineurium remains intact (49).  This is, therefore, an ideal injury model to 
test an injectable signaling molecule such as aLam. In the study described in the first part of this 
Chapter, we will test the hypothesis that aLam promotes axonal regeneration and functional 
recovery in a clinically relevant model of peroneal nerve crush. 
3.1.2 Materials and Methods 
To test the regenerative capability of aLam in vivo, we injected aLam polymers into the crushed 
peripheral nerve of adult rats and evaluated motor and sensory function over a course of ten 
weeks post injury and injection. The rats were then perfusion fixed and the peripheral nerve and 
DRGs prepared for histological assessment of axonal regeneration. 
3.1.2.1 Surgical Procedures 
Female adult Sprague Dawley rats (225-250g, n=21; Charles River Laboratory, Wilmington, MA 
USA) were anaesthetized using intraperitoneal injection of a cocktail of ketamine (60 mg/kg; 
Butlerschein, Dublin, OH USA) and Dexdomitor (0.5mg/kg; Pfizer, New York, NY USA)(7).  
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The right hind limbs was shaved and cleaned with 70% ethanol followed by Betadine® scrub 
(Figure 11A), the thigh muscles were exposed and separated to reveal the peroneal nerve and a 
30 sec crush was made using #5 f ine forceps (Fine Science Tool, Foster City, CA). The nerve 
was consistently crushed where it passed over the tendon, which was used as an anatomical 
marker to ensure consistency between rats and for nerve dissection at the end of the functional 
testing (Figure 11B and C).  The completeness of the crush was confirmed visually by the 
presence of a translucent band (Figure 11D, circled).  Two days after the crush, animals were 
randomly assigned into one of three groups (n=7/group) and their injured nerve was re-exposed 
and 3 μL of either aLam, nLam or PBS was injected into the injury site using a 10 µL Hamilton 
syringe fitted with a pulled glass needle.  The investigator performing the injections was blinded 
to the treatment groups.  Starting 14 d ays post injection (dpi), gait was tested using the 
DigiGaitTM Image Analysis System until 70 dpi.  T he investigators conducting the behavioral 
assessments were blinded to experimental group. 
After final behavioral testing, animals were anesthetized as described above and nerves 
were traced using a 3 µL injection of Cholera Toxin B subunit (CTB; 1% CTB in sterile diH2O; 
List Biological Laboratories, Campbell, USA) 10 mm distal to the crush site (63).   
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Figure 13 Peroneal Nerve Injury.  A. Right hind limb prepped for surgery. B. Muscles separated to reveal 
peroneal nerve.  Forceps indicated tendon used as anatomical marker of injury. C. 30 sec crush injury at anatomical 
marker with fine forceps. D. Circled area denotes translucent band indicative of axonotmesis crush injury. 
3.1.2.2 Post-Surgery Procedures 
Antisedan (1.5 mg/kg; Pfizer) was injected subcutaneously to reverse the effects of dexdomitor. 
An intramuscular injection of gentamicin (6 mg/kg; VWR), a subcutaneous injection of Rimadyl 
(5 mg/kg; Pfizer), and a subcutaneous Ringer’s solution (5 mL) were administered daily for two 
days post injury. After injection, all rats received three additional days of Rimadyl (5 mg/kg, 1x 
47 
daily). All rats were monitored daily throughout the course of experiment.  Autophagia of the 
injured limb may occur with this type of peripheral nerve crush.  At the first sign of autophagia, 
rats were treated with topical lidocaine, Zymox® with 1 % hydrocortisone, and bitter spray to 
heal the wounds and discourage future chewing.  All animals were supplied daily with paper huts 
to chew.  Rats were perfusion fixed with 0.01 M PBS followed by 4 % Paraformaldehyde (PFA) 
at 11 weeks post injury. 
3.1.2.3 Motor Function Assessment 
The DigiGaitTM Image Analysis System (Mouse Specifics, Framingham, MA, USA) was 
employed to investigate gait (Figure 16).  P reliminary study revealed the importance of 
acclimating rats to the DigiGaitTM prior to data collection.  F or acclimation, rats were first 
introduced into the DigiGaitTM chamber with the treadmill and lights off.  Then, for 8 min for 
four days, the rats were placed on the treadmill at a starting speed of 3 cm/sec which was slowly 
increased to the target speed of 20 c m/sec on the fourth day, at which time baseline 
measurements were recorded.  The target treadmill speed of 20 cm/sec (zero degree incline) was 
chosen because it requires continuous walking (no running) for all rats, but it is not so laborious 
that injury prevents successful participation for most animals.  Rats that did not walk at the target 
speed were excluded from the study.  The complete behavioral testing schedule was: 1 day prior 
to surgery (baseline), 14 dpi, then weekly up to 42 dpi and bi-weekly from 42-70 dpi.  The main 
motor outcome measure was Peroneal Function Index (PFI). 
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Figure 14 DigiGait® Automated Treadmill walking device and software to detect differences in gait.  
Top: Image of rat treadmill walking in chamber, bottom left: dynamic paw area and gait signal plots, bottom right: 
posture plots. 
3.1.2.4 Immunohystochemistry 
Following the 70 dpi behavioral measures, animals were anesthetized and transcardially 
perfused with 300 mL of 0.01M PBS followed by 400 mL of 4 % paraformaldehyde (PFA). A 5 
mm-long piece of the peroneal nerve centered on the crush site and the proximally adjacent 5 
mm-long section were dissected and post-fixed overnight in 4 %  PFA, followed by treatment 
with 30 % sucrose solution and storage at +4 ºC.  Then, 15 µm thick longitudinal sections were 
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cut in five series using a cryostat microtome at -24 ºC and mounted on pos itively charged 
microscope slides.  Nonspecific binding sites were blocked using 0.01M PBS with 5 % Normal 
Goat Serum (NGS) and 0.03 % Triton blocking solution at room temperature for 1h.  To evaluate 
nerve regeneration, sections were incubated with anti-neurofiliament-heavy type (NF-h) 
antibodies (1:250, Millipore AB1991) at 1 h at room temperature followed by overnight at +4 ºC.  
Neurofilament is a major component of the neuronal cytoskeleton, mainly found in the axon 
where it provides support and participates in axonal transport.  After washing with 0.01 M PBS, 
secondary antibody reaction was initiated using AlexaFluor 488 f luorescent antibodies against 
rabbit (1:1000, Molecular Probes) for 1 h at room temperature followed by 3x washing, DAPI 
counterstain, and covering with a glass slip using anti-fade fluorescent mounting media (Dako, 
#S3023, Carpenteria, CA, USA). The number and size of NF-h positive axons crossing the crush 
site were determined using a Zeiss Axio Observer inverted fluorescent microscope with Zeiss 
Plan Apochromat objective (20x air, NA 0.8) and quantified using ImageJ (58). 
3.1.2.5 Semi-thin nerve sections 
A 3 mm long piece of the peroneal nerve just distal to the crush was removed and post-fixed in 
2.5 % gluteraldehyde overnight in 4 ºC  for semi-thin sections.  T issue was then rinsed three 
times in PBS and then penetrated with OsO4 overnight.  After washing, the tissue was processed 
using serial drying with increasing concentrations of ethanol from 30 - 100 %.  Tissue was then 
treated with propylene oxide (PO), combination PO:Epon® (3:1, 1:1, 1:3), 100 %  Epon® and 
embedded in silicone molds with Epon® resin.  Following 24 h curing at 37 ºC and 48 h at 65 ºC, 
cross sections of nerve were cut using a diamond knife at a thickness of 400 nm and stained with 
toluidine blue for myelin analysis and quantification. 
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3.1.2.6 Myelin Quantification 
Toluidine blue (tolonium chloride) is a staining solution that at high pH will bind to nucleic acid 
and proteins.  The alkaline form is used here to delineate structural components of our semi-thin 
sections in order to quantify total myelinated fibers in cross sections of nerves just distal to the 
crush.  P reliminary data showed that while there were significant differences found when 
comparing more proximal sections of the nerve to those within the injury site, there was no 
difference in total area of myelination, size or number of myelinated fibers when comparing 
within the injury site to the adjacent distal section, therefore numbers here will be taken as 
representative of re-myelination across the injury.  Total area and number of myelinated fibers 
were quantified using ImageJ (58) particle analyzer and averaged per experimental group. 
3.1.2.7 Statistical Analysis 
Statistical analyses were performed using SPSS statistical software package (SPSS version 21, 
IBM).    O ne-way ANOVA with Tukey’s post hoc was used to measure histological differences 
between groups.  R epeated measures ANOVA with Tukey’s post hoc were used to evaluate 
differences in behavioral measures.  Differences were considered significant at p ≤ 0.05. 
3.1.3 Results 
3.1.3.1 Laminin treatment resulted in decreased autophagia  
Autophagia was characterized under two categories; early (before injection) and late (at least one 
week post injection).  If any blood was visible on t oenails or lacerations/ulcers on t he right 
hindpaw it was marked as autophagia.  Equal numbers of early autophagia occurred throughout 
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groups (n=2/7 for each group).  For late autophagia, the incidence was lowest in aLam treated 
rats (n=1/7) compared to nLam treated rats (n=2/7) or PBS treated rats (n=3/7). 
3.1.3.2 aLam treatment increased compliance for treadmill walking 
Prior to injury, baseline measures were taken from all animals and only those with perfect 
compliance were selected for the study.  Following crush injury, the group with aLam treatment 
remained at 100% compliance for treadmill walking at all behavioral time points.  In the nLam 
treatment group some animals refused to walk at the target speed at 28 and 70 dpi. In the PBS 
treatment group, there were several rats that refused to walk at the target speed at each time point 
after 14 dpi (Figure 13). 
Figure 15 Compliance for Automated Treadmill Walking. aLam group achieved 100% compliance for 
treadmill walking at every time point (aLam=blue, nLam=orange, PBS=grey) 
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3.1.3.3 No difference in peroneal function index at 70 dpi 
Repeated Measures ANOVA was conducted on standardized PFI data (timepoint-baseline) and 
no significant effect of group was found (p=0.07).  Nerve function in the aLam and nLam groups 
was similar (p=0.8) and both groups trended towards significance from the PBS group (p=0.07), 
but did not reach the set value. Results from PFI analysis and example of DigiGait hindpaw area 
graphs are depicted in Figure 14. 
Figure 16-Peroneal Function Index.  Left: DigiGait paw area graphs. Top graphs (blue/purple dots) 
represent forepaws and bottom graphs (green/red dots) represent hindpaw. Top pair is representative of 14 dpi and 
bottom pair of 70 d pi.  Bottom right hindpaw (red) has regained area indicative of functional recovery.  Right: 
Standardized PFI graph shows loss and return of function of right hindpaw in all groups along the course of the 
study (aLam(n=5), nLam(n=6), PBS (n=3)). 
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3.1.3.4 aLam treatment increased the number of large diameter axons at 70dpi 
NF-h staining was used to determine the amount of axon regeneration/sprouting across the injury 
site.  We found significantly more large diameter axons in the aLam group than in the nLam or 
PBS group (p<0.05).  There were no differences found in total number of fibers or total area of 
NF-h staining (p>0.05) (Figure 15). 
Figure 17 Peroneal Nerve Regeneration. Image:  Example of a crushed peripheral nerve 10 weeks post-
injury (A), at (B) and away (C) from the crushed site (NF-h (green) and DAPI (blue), Scale bar= 250 µm on A and 
50 µm on B and C). Graphs:  Significantly more large diameter axons found in aLam treatment group than nLam or 
PBS control at 70dpi (ANOVA, p<.05).  Overall total number or area of NF-h positive axons did not differ between 
groups. 
3.1.3.5 No difference in myelination of nerve between groups 
Myelin was quantified using the semi-thin sections stained with toluidine blue.  Five sections per 
animal were quantified and averaged.  Analysis showed no difference in total area or number of 
myelinated fibers between groups (Figure 16). 
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Figure 18 Myelin Quantification. Top: Semi-thin plastic sections stained with toluidine blue (Scale bar= 
50µm). Bottom: No difference observed in number of myelinated fibers or total area of myelin (PBS (grey), nLam 
(orange), aLam (blue), p>.05) 
3.1.4 Discussion 
Our in vitro studies described in Chapter 2 demonstrated that aLam can act as a s ignaling 
molecule promoting neurite growth from DRG neurons in vitro.  In the present study we 
investigated the repair potential of aLam using a clinically relevant in vivo model of peripheral 
nerve damage.  O ur findings partially supported our hypothesis showing that aLam treatment 
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resulted in enhanced axon regeneration.  We did not observe enhanced functional recovery.  The 
data suggests that 1) aLam increases compliance on t readmill running after injury; 2) aLam 
decreases autophagia, a common occurrence following PNI; 3) aLam was associated with 
significant increase in large diameter axons across the crush; 4) there were no s ignificant 
differences in area of myelination or number of myelinated axons; 5) there were no significant 
differences in motor recovery as measured by the peroneal function index. Together these results 
support the notion that aLam has potential for treatment as an injectable signaling molecule.  It 
showed increased biocompatibility and no additional damage or discomfort was observed in the 
rats. In fact, the decreased autophagia in the aLam group can be interpreted that aLam treatment 
alleviated discomfort normally associated with this type of injury.  Further research will be 
needed to elucidate aLam’s role in these findings.  
Although there were no overall significant differences in PFI, there appeared to be a trend 
towards earlier recovery in the polymerized laminin treatment groups.  Due to the low number of 
compliant controls in the behavioral evaluation, it is  difficult to say whether additional data 
would have further separated these findings into significance.  O ne could postulate that those 
animals which complied with the task demands represented only the highest functioning 
controls, whereas the aLam group data, with 100 % task compliance, was the most accurate 
representation of the three experimental groups.  If one were to include lower functioning 
controls, this difference may become more apparent, but additional studies, employing perhaps a 
less demanding, but equally sensitive behavioral measure, are needed to test this theory.  
One caveat of this model is that all groups showed improvement in motor function by 70 
dpi, at which point all histological data was collected and analyzed.  T he similar functional 
outcomes were in agreement with the lack of differences between groups in total number of 
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axons and myelination.  Peripheral axons exhibit a relative high intrinsic ability to grow and can 
reach growth speeds of 5 mm/week. Thus, it is possible that we missed the window at which we 
could have detected differences in total number of regenerated fibers.  Evaluation of histology at 
earlier time points after injury/treatment could provide additional information about the true 
potential of aLam treatment to promote axon regeneration and functional recovery after PNI.  
Alternatively, a more severe injury could provide additional data, but this also may further 
incapacitate our control group for behavioral measures. 
A clinically significant finding in our study is aLam’s effect on autophagia.  Autophagia 
is a common occurrence in peripheral nerve injury in rats and can lead to devastating self-
mutilations.   T he fact that aLam all but abolished this response underscores its potential for 
further development as a therapeutic for PNI. 
3.2 ACIDIC LAMININ FOR SPINAL CORD REPAIR 
3.2.1 Introduction 
The central nervous system (CNS) consists of the brain and spinal cord, which are 
physically separated from the rest of the body through the blood - brain/spinal cord – barrier. 
This barrier presents a unique challenge when developing systemically delivered treatments for 
repair. Due to the closed structure of the CNS, developing injectable treatments with minimally 
invasive delivery may be preferable.   Following traumatic injury, adult CNS neurons, although 
intrinsically capable of regeneration (64), do not  spontaneously regenerate damaged axons. 
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Strategies that promote axonal regeneration or plasticity after CNS injury are necessary for 
recovering disrupted motor and sensory circuits and reinstating functional flow of information 
between the brain and periphery.  In order for this to occur there are many obstacles to axon 
growth that one must overcome, including an abundance of inhibitory molecules, lack of growth-
promoting molecules and loss of matrix substrate. Laminin has been shown to be involved in 
growth promotion (25, 62) and as a guidance matrix (31, 65, 66) during development and after 
injury, making it an interesting candidate treatment for repair.  Our previous studies suggest 1) 
that aLam acts as an axon growth-promoting molecule in vitro, 2) aLam signals its growth 
effects through α1 and or α3 integrins, and 3) aLam can be employed as an injectable treatment 
to elicit growth responses in the damaged peripheral nerve. In the study described in this chapter, 
we will test the therapeutic potential of aLam for damaged central nervous tissue utilizing a 
clinically relevant model of spinal cord contusion injury.   
Our previous studies showed that polymerized laminin requires α1 and α3 integrin 
receptors to initiate growth signaling responses.  These laminin polymer-binding integrins are 
also mostly absent in healthy, uninjured, spinal cord tissue (Figure 19, A).  F ollowing a 
contusive SCI, there is a significant increase in both α1 and α3 integrin receptors at and around 
the injury site (Figure 19, B).  T his increase is at least in part attributed to an increase in 
expression on s pinal motor neurons, which show expression of one or both types of integrins 
(Figure 19, C (arrows)). 
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Figure 19 Integrin Expression after SCI.  A. α1 (red) and α3 (green) integrin expression in uninjured, 
healthy spinal cord thoracic segment. B. α1 (red) and α3 (green) integrin expression at three days post 200kDyne 
contusion injury (T9 spinal segment). C.  Increased magnification of injury site to show expression increase is (in 
part) due to an increase in expression of one (bottom arrow) or both (top arrows) integrins to varying degrees in 
motor neurons.  Note: Same camera and microscope settings used for A and B 
In this chapter, we will test the hypothesis that aLam promotes axonal growth in a contusion 
model of spinal cord injury thereby improving functional recovery. 
3.2.2 Materials and Methods 
3.2.2.1 Surgical Procedures 
A model of adult rat spinal cord contusion (7, 67, 68) was used to test axonal regenerative effects 
of aLam.  F emale adult Sprague Dawley rats (225-250 g, n = 30; Charles River Laboratory, 
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Wilmington, MA USA) were anaesthetized using intraperitoneal injection of a cocktail of 
ketamine (60 mg/kg; Butlerschein, Dublin, OH USA) and Dexdomitor (0.5 mg/kg; Pfizer, New 
York, NY USA) (7).  The dorsal surfaces of animals were shaved and then cleaned with 70 % 
ethanol followed by Betadine® scrub, the tenth thoracic spinal cord segment was exposed via 
laminectomy and contused using a force of 200 kDyne (Infinite Horizon IH-0400 impactor; 
Precision Systems and Instrumentation, LLC, Versailles, KY USA) (69) (Figure 20).  The injury 
site was rinsed with sterile saline containing 0.1 % gentamicin (VWR, Radnor, PA), the muscles 
were sutured in layers and the skin was closed with Michel wound clips (Find Science Tools, 
Foster City, CA USA).  Rats were included in the study based on receiving an impact within 5 % 
of the intended force and a Basso-Beattie-Bresnahan (BBB) (70, 71) score of ≤ 1 at day 1 and ≤ 
5 at day 3 post-contusion.  Three days post injury, which was previously identified as an optimal 
time point for therapeutic intervention (67), rats were randomized, sedated and 5 µL of either 
aLam (50 µg/mL), nLam (50 µg/mL) or 0.01 M PBS in was injected into the epicenter of the 
contusion by an investigator blinded to the treatment administered (Figure 20). 
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Figure 20 Spinal cord injury and injection.  A) Laminectomy was performed at thoracic level and B) T9 
spinal segment was exposed.  C) Contusion injury with Infinite Horizon impactor. D) Injection apparatus for 3dpi 
injection of aLam, nLam or PBS. 
3.2.2.2 Post-Surgery Procedures 
Antisedan (1.5 mg/kg; Pfizer) was injected subcutaneously to reverse the effects of dexdomitor. 
An intramuscular injection of gentamicin (6 mg/kg; VWR) and subcutaneous injections of 
Rimadyl (5 mg/kg; Pfizer) and Ringer’s solution (10 mL on the surgery day, 5 mL thereafter) 
were administered daily for three days post injury. After injection on the third day after injury, 
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rats received daily injections with gentamicin for four days Rimadyl and Ringer’s for three days.  
Bladders were expressed manually twice daily until reflex voiding returned.  A ll rats were 
monitored daily throughout the course of experiment and exhibited no sign of additional stress or 
pain response.  R ats were perfusion fixed with 1 x PBS followed by 4 % Paraformaldehyde 
(PFA) at seven weeks post injury. 
3.2.2.3 Motor Function Assessment 
All motor function assessments were conducted by one or more investigators (depending on the 
tested motor task) blinded to the treatment group.  O verground walking ability was assessed 
using the BBB test (70) (Figure 21) one and three days post injury and weekly thereafter 
(n=10/group).  Individual scores were averaged across paws and used for experimental group 
averages. Sensorimotor function was assessed using the horizontal ladder walking tests (aLam 
(n=10); nLam (n=7); PBS (n=9)) at three and six weeks post injury (Figure 21). Medium (foot 
and partial leg) and large (full leg) slips were counted and expressed as a percentage of the total 
number of steps. Percent scores were averaged across experimental group. Gait at a w alking 
speed of 20 cm/sec was assessed using the DigiGaitTM Image Analysis system (Figure 12) at one 
day prior to (baseline) (n=10/group) and six weeks post injury (aLam (n=7); nLam (n=9); PBS 
(n=9)).  Hind limb stride length was expressed as a percent of the baseline value and averaged 
between paws and within groups. 
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Figure 21 BBB and Horizontal Ladder.  A) Image of spinal cord injured rat completing BBB evaluation 
of overground walking.  B) Image of spinal cord injured rat transversing horizontal ladder sensorimotor task. 
3.2.2.4 Sensory Function Assessment 
All sensory function assessments were conducted by one or more investigators blinded to 
treatment group of rats.  Mechanical alloydynia was assessed using Von Frey hairs, previously 
shown to detect changes in sensitivity using this injury model (68).  A nimals were placed in 
Plexiglas boxes on a raised grid platform and allowed to acclimate until visibly relaxed and still. 
Rigid filaments were applied to the plantar surface of each hindpaw at increasing force (g) until 
withdrawal.  To reduce variability, test was repeated five times per paw at 5 min intervals and 
the middle three scores were recorded and averaged per time point. Testing was conducted at one 
day prior to (baseline) and three and six weeks post injury (n=10/group).  Scores were expressed 
as a percentage of the baseline score and averaged across paws and within groups.  
Thermal hypersensitivity was measured using the Hargreaves assay (72).  R ats were 
placed in Plexiglas boxes on a  raised glass platform and allowed to acclimate until visibly 
relaxed and still.  A  high-intensity beam of light was focused on the plantar surface of each 
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hindpaw and seconds to withdrawal was measured.  The active beam intensity was set at 25 %, 
resting intensity at 5 %, and cutoff at 20 sec to ensure no t issue damage was done. To reduce 
variability, test was repeated five times per paw at 5 min intervals and the middle three scores 
were recorded and averaged per time point. Testing was conducted at one day prior to (baseline) 
and three and six weeks post injury (n=10/group).  Scores are expressed as a percentage of the 
baseline score and averaged across paws and within groups. 
3.2.2.5 Anterograde and Retrograde Tracing 
Biotinylated Dextran Amine (10 % BDA, 10,000 MW; Molecular Probes, #D1956, Lot: 
1476602) was inject bilaterally into the motor cortex six weeks post injury.  The skull was 
exposed and two small diameter holes were drilled directly above the motor cortex.  Three µL of 
1 % BDA was injected per hemisphere to anterogradely trace the corticospinal axons. Traced 
axons were visualized using TSA Cyanide-3 Amplification Kit (PerkinElmer, 
NEL704A1001KT).  Labeled axons 1 mm above and below the lesion cavity were counted, 
multiplied by ten (one out of ten sections were used for quantification) and expressed as percent 
regenerated/spared ((below/above)*100).  Totals were averaged per experimental group. 
 Retrograde tracing was performed using 2 % Fast Blue (0.6µL each spinal hemisphere; 
Sigma, #F337813), injected 10 mm caudal to injury.  Brainstem sections were cut into ten series 
using the cryostat microtome (40 µm, -24 ºC, free-floating).  One series was mounted on 
positively charged slides and the total number of labeled neurons in the red nuclei was counted 
using a Zeiss Plan Apochromat objective (20x air, NA 0.8).  The numbers were multiplied by ten 
and averaged per group. 
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3.2.2.6 Histology 
Ten days after injection of tracer, animals were deeply anesthetized (100 mg/kg Ketamine) and 
transcardially perfused with 300 mL of 0.01 M PBS followed by 400 mL of 4 % 
paraformaldehyde (PFA).  Spinal cords were then dissected and post-fixed overnight at 4 ºC in 4 
% PFA then transferred into a cryoprotective 30 % sucrose solution and stored at 4 ºC.  A 15 
mm-long piece of the spinal cord centered on the injury site was dissected from spinal cord cut 
into 10 s eries of 15 µm-thick horizontal sections on a cryostat microtome and mounted on 
positively charged microscope slides.  One series was used for Nissl staining for spared tissue 
quantification.  All other series were used for immunohistochemistry. 
3.2.2.7 Immunohistochemistry 
Nonspecific binding sites were blocked using 0.01M PBS with 5 % Normal Goat Serum (NGS) 
and 0.03 % Triton blocking solution at room temperature for 30 min.  Tissue was then incubated 
with primary antibodies against astrocytes (GFAP; DAKO, 1:200) and neurofilament-h (RT-97; 
Millipore, 1:200) diluted in blocking solution for 2 h at room temperature or overnight in 4 ºC.  
Fluorescent secondary antibodies diluted in 0.01 M PBS (Alexa Fluor®, life technologies, 1:500) 
were added for 1 h  at room temperature, followed by DAPI counterstaining and covered with 
glass slips with anti-fade fluorescent mounting media (Dako, #S3023, Carpenteria, CA USA). 
Tissue was evaluated using a Zeiss Axio Observer inverted fluorescent microscope with Zeiss 
Plan Apochromat objective (20x air, NA 0.8), and StereoInvestigator® (MBF Biosciences, Inc.) 
software.   
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3.2.2.8 Spared Tissue Quantification 
Nissl stained sections were used to determine the volume of spared tissue within the area of 
injury using a Zeiss Axio Observer inverted microscope and the Cavalieri estimator function of 
StereoInvestigator software (MicroBrightField, Inc).  Analysis was performed by an investigator 
blinded to experimental condition.  The spared tissue areas of all sections were used to calculate 
the volume of spared tissue in the series and multiplied by 10 to represent tissue across the entire 
cord segment, totals were averaged per experimental group (n=10/group).   
3.2.2.9 Statistical Analysis 
Factorial ANOVA with Tukey’s post hoc was used to analyze histological and tracing 
differences between groups.  R epeated measures mixed ANOVA with Tukey’s post hoc was 
used to evaluated differences in behavioral measures.  Significance was set at p ≤ 0.05. 
3.2.3 Results 
3.2.3.1 Laminin did not affect motor function recovery 
Multiple tests were conducted to comprehensively evaluate motor function in the injured and 
treated rats.  Laminin polymer treatment did not affect overground walking as measured by the 
BBB or sensorimotor function as measured by the horizontal ladder test (Figure 22). Differences 
in gait were assessed using the DigiGait and no effect of group was found in stride length and 
paw rotation, outcome measures that normally are associated with SCI (Figure 23). 
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Figure 22 BBB and Horizontal ladder. Polymerized laminin did not affect recovery of overground 
walking (BBB; p=0.4) or sensorimotor integration (horizontal ladder; p=0.7) 
Figure 23 Gait Analysis.  Polymerized laminin injection did not affect gait recovery measurements at 6 
weeks post injury (MANOVA, Stride length; p=0.68, Paw angle; p=0.49) 
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3.2.3.2 Laminin did not affect sensory function recovery 
In order to evaluate sensory function, the Hargreaves test was used to assess thermal 
hyperalgesia and the Von Frey test for mechanical allodynia. We found that none of the injured 
and treated animals developed allodynia (data not shown).  All rats exhibited symptoms of 
thermal hyperalgesia.  The control group and the nLam-treated group had higher sensitivity for 
the thermal stimulus than the aLam-treated group, but the group differences did not reach 
statistical significance (p=0.5) (Figure 24). 
Figure 24-Thermal Hyperalgesia. Thermal hyperalgesia was measured using the Hargreaves method 
(resting intensity 5%, active intensity 25%, 20sec max).  N o main effect of group was observed using repeated 
measures ANOVA (p=0.5). 
3.2.3.3 Laminin polymers decrease astrocyte activation 
Astrocyte activation was measured using antibodies against glial-fibrillary acidic protein 
(GFAP).  Laminin polymer treatment resulted in a significant effect of group (p=0.008) showing 
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significant decreases in staining intensity of GFAP relative to the PBS group (PBS vs aLam or 
nLam, p<0.05) (Figure 25). No difference in the effects of aLam and nLam on astrocyte activity 
was detected (p=0.85).   
3.2.3.4 aLam did not affect axon intensity at injury site 
Axons were identified using antibodies against neurofilament-h and the staining intensity 
measured. We found a significant effect of group (p=0.01).  T ukey’s post hoc revealed aLam 
treatment did not affect axon intensity relative to PBS group.  nLam treatment, however, showed 
significantly decreased axon intensity across the injury site relative to PBS (Figure 25, p<0.01).  
Figure 25 Astrocyte Activation and Axons. Significant decrease in GFAP intensity at the injury site in 
laminin treatment groups (p<0.05). Significant decrease in axon intensity at injury site in nLam group vs PBS 
(p<0.01), no difference between PBS and aLam group.  Image: GFAP (green), RT97 (neurofilament, red), DAPI 
(blue). 
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3.2.3.5 Anterograde and Retrograde tracing 
Fast Blue (FB) retrograde tracing and BDA anterograde tracing were used to determine 
number of axons originating from the red nuclei or primary motor cortex, respectively.  There 
was no effect of group on either population of axons (Figure 26). 
Figure 26 Tracing Quantification.  A) Fast blue traced neurons in the red nucleus (Scale bar=100µm).  
No difference between groups was observed (ANOVA, p=.8).  B )  B DA traced axons at the injury site (Scale 
bar=100µm).  Graph expresses count 1mm below injury as a percentage of 1mm above injury cavity.  No effect of 
group (ANOVA, p=.77). 
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3.2.3.6 Polymerized laminin had no effect on tissue sparing 
Nissl staining was used to enable identification of lost tissue and analysis of spared tissue in the 
contused segment.  I njection of laminin polymers did not affect the volume of spared tissue 
(p=0.2) (Figure 27). 
Figure 27 Tissue Sparing.  Nissl staining of spinal segments were quantified for total volume (Scale bar= 
100µm).  Graph represents group means with 95% confidence interval.  No effect of group (ANOVA, p=.26) 
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3.2.4 Discussion 
Our results from the study described in Chapter 3.1, suggested that aLam elicits axonal 
growth responses in an injured peripheral nerve.  H ere, we have evaluated whether aLam 
promotes axonal responses in the contused adult rat spinal cord. Our findings suggest that 1) 
laminin polymers do not affect the total number of axons in general, and corticospinal or 
rubrospinal tract fibers specifically at the injury site; 2) laminin polymers do not affect motor or 
sensory recovery at six weeks following an injury; 3) laminin polymer presence decreases 
astrocyte activation; 5) laminin polymer injections do not  affect spared tissue volume. In 
summary, aLam reduced astrocytic activation in the contused spinal cord segment, but this did 
not result in enhanced axon regeneration and functional recovery.    
The lack of effects on axon responses by aLam may suggests that the timing of the 
treatment or the concentration/amount of the injected laminin polymer was suboptimal for 
eliciting an effect.  SCI presents an environment full of inhibitory molecules and high levels of 
inflammation.  It is a daunting task to overcome the many growth-inhibitory factors in order to 
elicit regeneration.  A mong the inhibition encountered at the lesion site is reactive astrocytes 
composing the glial scar.  This ‘scar’ form a physical and chemical barrier to growth surrounding 
the injury.  An immediate injection may better utilize aLam’s effect on astrocyte activation and 
could be more suitable for decreasing inhibition in order to observe optimal benefits from its 
growth-promoting abilities. Another consideration is the site of injection.  O ur integrin 
immunostaining before and after injury indicated an increased expression on m otor neurons 
above and below the epicenter, perhaps multiple injections in those locations would prove more 
favorable than a single injection into the epicenter.  Future research will be necessary to elucidate 
the validity of these possible explanations.  
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4.0  SUMMARY AND GENERAL DISCUSSION 
Together the results obtained from the experiments described in this thesis provide a thorough 
evaluation of the in vitro and in vivo potential of laminin polymerized under acidic pH conditions 
for neurite extension and axon regeneration.  In the first part of our in vitro work using a novel 
developed model system (Chapter 2.1),  our results provided information about the integrin 
receptor targets of aLam to enhance neurite growth competence of adult neurons and that aLam 
elicits compensatory measures to up regulate α3 integrins in the ‘absence’ of availability of α1 
integrins.  The data also showed that aLam enhances neurite outgrowth by increasing focal 
adhesion complex formation, which is necessary for actin polymerization and axon extension.  
That aLam elicits its response through multiple growth-promoting binding sites and can initiate a 
compensatory response in the absence of one is an important characteristic because it increases 
the overall impact of aLam as a t reatment for nervous tissue repair.  Integrin expression is a 
dynamic process following injury, as is evidenced from the significant increase in expression of 
α1 and α3 at three days after SCI.  As the injury environment changes with time, it has been 
shown  that integrin expression changes as well (73).  Detailed information on l ongitudinal 
integrin expression profiles in response to a specific injury mechanism is needed to fully realize 
the potential therapeutic window of aLam.  
In second part of our in vitro work (Chapter 2.2), we showed that microcontact printing is 
an appropriate way to observe directed growth of neurons cultured on growth-neutral PDL 
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substrates and that when translated to the live imaging environment, attached neurons are able to 
remain viable in this system for long periods of time, regardless if they were imaged using the 
Bioptechs chamber or culture dishes.  This is an important proof of concept to take into 
consideration in the design of future live imaging experiments.  This finding suggests that our 
PDL concentration, media components, and choices of imaging modality and duration are all 
appropriate for these types of neurons.  Optimizing this system to retain greater cell adhesion and 
growth in order to be able to evaluate dynamic interactions is an important next step. 
In the in vivo experiments (Chapter three) we found that aLam injected into a damaged 
peripheral nerve, resulted in an axonal regeneration response.  In addition, aLam treatment 
decreased autophagia and increased treadmill task compliance.  Our spinal cord data revealed 
that the effect of aLam is not exclusive to neurons, which was apparent through the decrease in 
activated astrocytes at the injury site.  H owever, since this action did not result in enhanced 
growth in our model system, it is  impossible to definitively determine from the present results 
whether it is related to regeneration, or an unrelated, potentially beneficial side effect. 
Our first goal of this thesis was to utilize a novel in vitro system to test the molecular and 
cellular mechanisms of aLam as a growth-promoting molecule.  In Chapter 2.1 we successfully 
tested our novel in vitro system and our results revealed that aLam maintains its growth-
promoting effects through binding of the α1 and α3 integrin receptors and increasing focal 
adhesion complex formation.  O ur second goal was to employ microcontact printing and live 
imaging to create a system in which to study aLam’s effect on growth cone dynamics and glial 
cell involvement.  Early results from this support the feasibility of utilizing this technique in that 
we were able to achieve directed growth on PDL stamped substrates in culture and cells retained 
viability for the duration of the live imaging.  Together these suggests that with optimization of 
74 
pattern and technique, microcontact printing of PDL and live imaging would be an appropriate 
and valuable combination tool for use in the assessment of neural growth dynamics with 
unbound signaling molecules.  O ur third goal was to test the repair potential of aLam as an 
injectable regenerative therapeutic using an adult rat model of PNI.  T his was accomplished 
using a clinically relevant model of rat peroneal crush injury.  Results showed that aLam elicited 
therapeutic effects on axon growth, task compliance and autophagia.  Axon growth effects did 
not lead to improvements in motor function.  R esults on a utophagia are novel and clinically 
relevant and future studies should be conducted to better understand this phenomenon.  O ur 
fourth goal was to test the repair potential of aLam as an injectable regenerative therapeutic 
using an adult rat model of SCI.  This was accomplished using a clinically relevant model of 
contusion SCI.  R esults showed that aLam did not elicit axon regeneration or functional 
recovery.  There was a novel and clinically relevant aLam-mediated decrease in activated glia at 
and surrounding the contusion.  
Taken together we have shown here that organization of polymerized laminin can have 
significant impact on how it interacts with receptors and promotes signaling for growth and that 
this signaling is not substrate attachment dependent, but rather acts as an unbound environmental 
signaling ligand.  This increases the potential impact for treatment development in that it retains 
the potential for use in delicate tissues and ‘closed systems’ where injectable treatments are 
preferable because they cause minimal addition damage to nervous tissue.  Our results here 
indicate that the differences found between aLam and nLam could be due to their structure. 
Further work is needed to definitively determine if structural differences are underlying changes 
observed in receptor interaction and growth-promotion.  Elucidating meaningful differences in 
three dimensional structure of this polymer could impact the development of novel biomaterials 
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as well as future consideration in the use of ECM proteins for signaling and repair.  Our goals 
stated above have been accomplished through new, innovative approaches accompanying time-
tested established models.  The marriage of these allowed for us to reveal novel and interesting 
results that could potentially change the way people think about and test extracellular matrix 
molecules for injectable therapeutics.   
Although aLam did not, in our model, promote axon regeneration that led to functional 
repair in vivo, the combined studies provided important groundwork for engineering new, more 
efficient molecular structures for specific targeting of multiple integrin receptors for neural 
regeneration.   
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